NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1878422027|gb|KAF5907254|]
View 

Serine/threonine-protein kinase mTOR, partial [Clarias magur]

Protein Classification

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
PIKKc_TOR cd05169
Catalytic domain of Target of Rapamycin; TOR contains a rapamycin binding domain, a catalytic ...
649-927 0e+00

Catalytic domain of Target of Rapamycin; TOR contains a rapamycin binding domain, a catalytic domain, and a FATC (FRAP, ATM and TRRAP, C-terminal) domain at the C-terminus. It is also called FRAP (FK506 binding protein 12-rapamycin associated protein). TOR is a central component of the eukaryotic growth regulatory network. It controls the expression of many genes transcribed by all three RNA polymerases. It associates with other proteins to form two distinct complexes, TORC1 and TORC2. TORC1 is involved in diverse growth-related functions including protein synthesis, nutrient use and transport, autophagy and stress responses. TORC2 is involved in organizing cytoskeletal structures. TOR is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). The TOR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


:

Pssm-ID: 270713 [Multi-domain]  Cd Length: 279  Bit Score: 619.50  E-value: 0e+00
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  649 IQSIAPSLQVITSKQRPRKLTIMGSNGHEFMFLLKGHEDLRQDERVMQLFGLVNTLLANDPASLRKNLSIQRYAVIPLST 728
Cdd:cd05169      1 ISSFDPTLEVITSKQRPRKLTIVGSDGKEYKFLLKGHEDLRLDERVMQLFGLVNTLLKNDSETSRRNLSIQRYSVIPLSP 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  729 NSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMEKVEVFEHAVNNTAGDDLAKLLWLKSPSSEV 808
Cdd:cd05169     81 NSGLIGWVPGCDTLHSLIRDYREKRKIPLNIEHRLMLQMAPDYDNLTLIQKVEVFEYALENTPGDDLRRVLWLKSPSSEA 160
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  809 WFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGL 888
Cdd:cd05169    161 WLERRTNFTRSLAVMSMVGYILGLGDRHPSNIMLDRLTGKVIHIDFGDCFEVAMHREKFPEKVPFRLTRMLVNAMEVSGV 240
                          250       260       270
                   ....*....|....*....|....*....|....*....
gi 1878422027  889 DGNYRITCHTVMEVLREHRDSVMAVLEAFVYDPLLNWRL 927
Cdd:cd05169    241 EGTFRSTCEDVMRVLRENKDSLMAVLEAFVHDPLISWRL 279
TEL1 super family cl34875
Phosphatidylinositol kinase or protein kinase, PI-3 family [Signal transduction mechanisms];
31-1043 1.28e-176

Phosphatidylinositol kinase or protein kinase, PI-3 family [Signal transduction mechanisms];


The actual alignment was detected with superfamily member COG5032:

Pssm-ID: 227365 [Multi-domain]  Cd Length: 2105  Bit Score: 589.83  E-value: 1.28e-176
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027   31 WGLGHWDSMEEYTCMIPRDTHDGAFY--RAVLALHQDLFslaqQCIDK-----ARDLLDAELTAMA-GESYSRAYGAMVS 102
Cdd:COG5032   1161 EQVGEWYKAQQLYEVAQRKARSKEFPfsLQYLYWHINDI----DCADKlqsvlAELSLVTGISELLlEESWRRALFSNIK 1236
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  103 CQMLSELEEVI--QYKLVPE-----RRDIIRETWWERLQG---CQRIVEDWQRILMVRSLVINPHEDMRTWLKYASLCGK 172
Cdd:COG5032   1237 DSLESELEEIIdgMYKSNEDfgalmLLSLSAELWDKILEGrssCSKSIKLSLNIWLDLSIVVSPKDEPELFIKFVELCEA 1316
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  173 SG-RLALAHKTLVLLLG---VDPSKqLDQPLPTAHPHVTYAYMKYMWKSARKIEAFQHMQHF----VQAMQQKAQHAIAA 244
Cdd:COG5032   1317 SSiRSKLLEKNIQELLEkleEIKSP-LGTLRDRLPPPWALLDLKRLLATWRQNAFLRINPELlpllSSLLNLQSSSLSKQ 1395
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  245 EDQQQKQE-------LHKLMARCFLKLGEWQLSLQ-GINESTIPKVLQYYSHSTEHDRNWYKAWHA-WAVMNFEAVLHYK 315
Cdd:COG5032   1396 LVSRGSSEsaisinsFASVARKHFLPDNQLKKIYQlSNILISEAFLLLRYLLLCRLGRRELKAGLNvWNLTNLELFSDIQ 1475
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  316 hqnqgrdekkklrhasgasgasanseasnsdseadsadhspvpspgQKKVNEDLSKTLLLYTVPAVQGFFRSISLSRGNN 395
Cdd:COG5032   1476 ----------------------------------------------ESEFFEWGKNLKLLSIIPPIEEIFLSNALSCYLQ 1509
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  396 LQDTLRVLTLWFDYGHWPEVNEALVEGIKTIQIDT-WLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTV 474
Cdd:COG5032   1510 VKDLLKKLNLFELLGSLLSAKDAAGSYYKNFHIFDlEISVIPFIPQLLSSLSLLDLNSAQSLLSKIGKEHPQALVFTLRS 1589
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  475 ASKSTTTARHNAANKILKNMCEHCNTLVQQAIMVSEELIR-VAILWHEMWHEGLEEASRLYFGERN-VKGMFAVLEPLHA 552
Cdd:COG5032   1590 AIESTALSKESVALSLENKSRTHDPSLVKEALELSDENIRiAYPLLHLLFEPILAQLLSRLSSENNkISVALLIDKPLHE 1669
                          570       580       590       600       610       620       630       640
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  553 MMERGPQTLKETSFNQAYGRDLMEAQDWCRKYMRSGNVKDLTQAWDLYYHVFRRIAKQLPQLTSLELQYVSPKLL-MCRD 631
Cdd:COG5032   1670 ERENFPSGLSLSSFQSSFLKELIKKSPRKIRKKFKIDISLLNLSRKLYISVLRSIRKRLKRLLELRLKKVSPKLLlFHAF 1749
                          650       660       670       680       690       700       710       720
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  632 LELAVPGTYDPNQPIIRIQSIAPSLQVITS-KQRPRKLTIMGSNGHEFMFLLKGHEDLRQDERVMQLFGLVNTLLANDPA 710
Cdd:COG5032   1750 LEIKLPGQYLLDKPFVLIERFEPEVSVVKShLQRPRRLTIRGSDGKLYSFIVKGGDDLRQDELALQLIRLMNKILKKDKE 1829
                          730       740       750       760       770       780       790       800
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  711 SLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRimlrMAPDYDHLTLMEKVEVFEHAVNNT 790
Cdd:COG5032   1830 TRRRDLWIRPYKVIPLSPGSGIIEWVPNSDTLHSILREYHKRKNISIDQEKK----LAARLDNLKLLLKDEFFTKATLKS 1905
                          810       820       830       840       850       860       870       880
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  791 AgDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEK 870
Cdd:COG5032   1906 P-PVLYDWFSESFPNPEDWLTARTNFARSLAVYSVIGYILGLGDRHPGNILIDRSSGHVIHIDFGFILFNAPGRFPFPEK 1984
                          890       900       910       920       930       940       950       960
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  871 IPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHRDSVMAVLEAFVYDPLLNWRLMdtntkgtkrsrtrtdsysagqs 950
Cdd:COG5032   1985 VPFRLTRNIVEAMGVSGVEGSFRELCETAFRALRKNADSLMNVLELFVRDPLIEWRRL---------------------- 2042
                          970       980       990      1000      1010      1020      1030      1040
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  951 vetmegidlgetthkkpgttvPESihsfigdglvqPEALNKKAIQIINRVRDKLTGRDFSHDETLDVPTQVELLIKQATS 1030
Cdd:COG5032   2043 ---------------------PCF-----------REIQNNEIVNVLERFRLKLSEKDAEKFVDLLINKSVESLITQATD 2090
                         1050
                   ....*....|...
gi 1878422027 1031 HENLCQCYIGCMA 1043
Cdd:COG5032   2091 PFQLATMYIGWMP 2103
Rrp6p_like_exo cd06147
DEDDy 3'-5' exonuclease domain of yeast Rrp6p, human polymyositis/scleroderma autoantigen ...
1296-1485 5.25e-116

DEDDy 3'-5' exonuclease domain of yeast Rrp6p, human polymyositis/scleroderma autoantigen 100kDa, and similar proteins; Yeast Rrp6p and its human homolog, the polymyositis/scleroderma autoantigen 100kDa (PM/Scl-100), are exosome-associated proteins involved in the degradation and processing of precursors to stable RNAs. Both proteins contain a DEDDy-type DnaQ-like 3'-5' exonuclease domain possessing three conserved sequence motifs termed ExoI, ExoII and ExoIII, with a specific YX(3)D pattern at ExoIII. The motifs are clustered around the active site and contain four conserved acidic residues that serve as ligands for the two metal ions required for catalysis. PM/Scl-100, an autoantigen present in the nucleolar compartment of the cell, reacts with autoantibodies produced by about 50% of patients with polymyositis-scleroderma overlap syndrome.


:

Pssm-ID: 99850 [Multi-domain]  Cd Length: 192  Bit Score: 364.61  E-value: 5.25e-116
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1296 ETNCQFISSLEDLAALNEKLNQTTEFAVDLEHHSYRSFLGITCLMQISTREEDFIIDTLELRSEMYVLNESFTNPSIVKV 1375
Cdd:cd06147      2 ETPLTFVDTEEKLEELVEKLKNCKEIAVDLEHHSYRSYLGFTCLMQISTREEDYIVDTLKLRDDMHILNEVFTDPNILKV 81
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1376 FHGADSDIEWLQKDFGLYVVNMFDTHQASRSLNLGRNSLDHLLKVFCNVDSNKRFQLADWRIRPLPEEMIKYAQADTHYL 1455
Cdd:cd06147     82 FHGADSDIIWLQRDFGLYVVNLFDTGQAARVLNLPRHSLAYLLQKYCNVDADKKYQLADWRIRPLPEEMIKYAREDTHYL 161
                          170       180       190
                   ....*....|....*....|....*....|.
gi 1878422027 1456 LYVYDRLRADLFDAAN-GQPALIQLVWSKSK 1485
Cdd:cd06147    162 LYIYDRLRNELLERANaLAPNLLESVLNCSR 192
PMC2NT pfam08066
PMC2NT (NUC016) domain; This domain is found at the N-terminus of 3'-5' exonucleases with HRDC ...
1089-1178 8.80e-28

PMC2NT (NUC016) domain; This domain is found at the N-terminus of 3'-5' exonucleases with HRDC domains, and also in putative exosome components.


:

Pssm-ID: 462352  Cd Length: 89  Bit Score: 108.42  E-value: 8.80e-28
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1089 VGATKASAGLPqaGDEYDFYRSF-PGFQDFCAVQGDRILHCMSQLMQHHGCRSHLRDRNKLTGLEERFDMVVDANDAILE 1167
Cdd:pfam08066    1 VSTTRAANALP--AQDIDFYRSLdPEFAESLDEQSARLLSLINSLLQSAGSKSNIKAPGDLDDVEDRWDSVVDVNDSLLE 78
                           90
                   ....*....|.
gi 1878422027 1168 KVGILLDEASG 1178
Cdd:pfam08066   79 KADICLDELTG 89
HRDC smart00341
Helicase and RNase D C-terminal; Hypothetical role in nucleic acid binding. Mutations in the ...
1516-1594 3.52e-16

Helicase and RNase D C-terminal; Hypothetical role in nucleic acid binding. Mutations in the HRDC domain cause human disease.


:

Pssm-ID: 128635 [Multi-domain]  Cd Length: 81  Bit Score: 75.03  E-value: 3.52e-16
                            10        20        30        40        50        60        70
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1878422027  1516 QQLSAFRFMYAWRDKLAREEDESTGYILPNHMMMKISEELPKEPQGIIACCNPTPPLVRQQINELHQLIKQAREIPLLK 1594
Cdd:smart00341    3 RQLRLLRRLRQWRDEIARREDVPPYFVLPDETLIKMAAALPTNVSELLAIDGVGEEKARRYGKDLLAVIQEASDSPSEA 81
 
Name Accession Description Interval E-value
PIKKc_TOR cd05169
Catalytic domain of Target of Rapamycin; TOR contains a rapamycin binding domain, a catalytic ...
649-927 0e+00

Catalytic domain of Target of Rapamycin; TOR contains a rapamycin binding domain, a catalytic domain, and a FATC (FRAP, ATM and TRRAP, C-terminal) domain at the C-terminus. It is also called FRAP (FK506 binding protein 12-rapamycin associated protein). TOR is a central component of the eukaryotic growth regulatory network. It controls the expression of many genes transcribed by all three RNA polymerases. It associates with other proteins to form two distinct complexes, TORC1 and TORC2. TORC1 is involved in diverse growth-related functions including protein synthesis, nutrient use and transport, autophagy and stress responses. TORC2 is involved in organizing cytoskeletal structures. TOR is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). The TOR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270713 [Multi-domain]  Cd Length: 279  Bit Score: 619.50  E-value: 0e+00
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  649 IQSIAPSLQVITSKQRPRKLTIMGSNGHEFMFLLKGHEDLRQDERVMQLFGLVNTLLANDPASLRKNLSIQRYAVIPLST 728
Cdd:cd05169      1 ISSFDPTLEVITSKQRPRKLTIVGSDGKEYKFLLKGHEDLRLDERVMQLFGLVNTLLKNDSETSRRNLSIQRYSVIPLSP 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  729 NSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMEKVEVFEHAVNNTAGDDLAKLLWLKSPSSEV 808
Cdd:cd05169     81 NSGLIGWVPGCDTLHSLIRDYREKRKIPLNIEHRLMLQMAPDYDNLTLIQKVEVFEYALENTPGDDLRRVLWLKSPSSEA 160
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  809 WFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGL 888
Cdd:cd05169    161 WLERRTNFTRSLAVMSMVGYILGLGDRHPSNIMLDRLTGKVIHIDFGDCFEVAMHREKFPEKVPFRLTRMLVNAMEVSGV 240
                          250       260       270
                   ....*....|....*....|....*....|....*....
gi 1878422027  889 DGNYRITCHTVMEVLREHRDSVMAVLEAFVYDPLLNWRL 927
Cdd:cd05169    241 EGTFRSTCEDVMRVLRENKDSLMAVLEAFVHDPLISWRL 279
TEL1 COG5032
Phosphatidylinositol kinase or protein kinase, PI-3 family [Signal transduction mechanisms];
31-1043 1.28e-176

Phosphatidylinositol kinase or protein kinase, PI-3 family [Signal transduction mechanisms];


Pssm-ID: 227365 [Multi-domain]  Cd Length: 2105  Bit Score: 589.83  E-value: 1.28e-176
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027   31 WGLGHWDSMEEYTCMIPRDTHDGAFY--RAVLALHQDLFslaqQCIDK-----ARDLLDAELTAMA-GESYSRAYGAMVS 102
Cdd:COG5032   1161 EQVGEWYKAQQLYEVAQRKARSKEFPfsLQYLYWHINDI----DCADKlqsvlAELSLVTGISELLlEESWRRALFSNIK 1236
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  103 CQMLSELEEVI--QYKLVPE-----RRDIIRETWWERLQG---CQRIVEDWQRILMVRSLVINPHEDMRTWLKYASLCGK 172
Cdd:COG5032   1237 DSLESELEEIIdgMYKSNEDfgalmLLSLSAELWDKILEGrssCSKSIKLSLNIWLDLSIVVSPKDEPELFIKFVELCEA 1316
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  173 SG-RLALAHKTLVLLLG---VDPSKqLDQPLPTAHPHVTYAYMKYMWKSARKIEAFQHMQHF----VQAMQQKAQHAIAA 244
Cdd:COG5032   1317 SSiRSKLLEKNIQELLEkleEIKSP-LGTLRDRLPPPWALLDLKRLLATWRQNAFLRINPELlpllSSLLNLQSSSLSKQ 1395
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  245 EDQQQKQE-------LHKLMARCFLKLGEWQLSLQ-GINESTIPKVLQYYSHSTEHDRNWYKAWHA-WAVMNFEAVLHYK 315
Cdd:COG5032   1396 LVSRGSSEsaisinsFASVARKHFLPDNQLKKIYQlSNILISEAFLLLRYLLLCRLGRRELKAGLNvWNLTNLELFSDIQ 1475
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  316 hqnqgrdekkklrhasgasgasanseasnsdseadsadhspvpspgQKKVNEDLSKTLLLYTVPAVQGFFRSISLSRGNN 395
Cdd:COG5032   1476 ----------------------------------------------ESEFFEWGKNLKLLSIIPPIEEIFLSNALSCYLQ 1509
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  396 LQDTLRVLTLWFDYGHWPEVNEALVEGIKTIQIDT-WLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTV 474
Cdd:COG5032   1510 VKDLLKKLNLFELLGSLLSAKDAAGSYYKNFHIFDlEISVIPFIPQLLSSLSLLDLNSAQSLLSKIGKEHPQALVFTLRS 1589
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  475 ASKSTTTARHNAANKILKNMCEHCNTLVQQAIMVSEELIR-VAILWHEMWHEGLEEASRLYFGERN-VKGMFAVLEPLHA 552
Cdd:COG5032   1590 AIESTALSKESVALSLENKSRTHDPSLVKEALELSDENIRiAYPLLHLLFEPILAQLLSRLSSENNkISVALLIDKPLHE 1669
                          570       580       590       600       610       620       630       640
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  553 MMERGPQTLKETSFNQAYGRDLMEAQDWCRKYMRSGNVKDLTQAWDLYYHVFRRIAKQLPQLTSLELQYVSPKLL-MCRD 631
Cdd:COG5032   1670 ERENFPSGLSLSSFQSSFLKELIKKSPRKIRKKFKIDISLLNLSRKLYISVLRSIRKRLKRLLELRLKKVSPKLLlFHAF 1749
                          650       660       670       680       690       700       710       720
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  632 LELAVPGTYDPNQPIIRIQSIAPSLQVITS-KQRPRKLTIMGSNGHEFMFLLKGHEDLRQDERVMQLFGLVNTLLANDPA 710
Cdd:COG5032   1750 LEIKLPGQYLLDKPFVLIERFEPEVSVVKShLQRPRRLTIRGSDGKLYSFIVKGGDDLRQDELALQLIRLMNKILKKDKE 1829
                          730       740       750       760       770       780       790       800
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  711 SLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRimlrMAPDYDHLTLMEKVEVFEHAVNNT 790
Cdd:COG5032   1830 TRRRDLWIRPYKVIPLSPGSGIIEWVPNSDTLHSILREYHKRKNISIDQEKK----LAARLDNLKLLLKDEFFTKATLKS 1905
                          810       820       830       840       850       860       870       880
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  791 AgDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEK 870
Cdd:COG5032   1906 P-PVLYDWFSESFPNPEDWLTARTNFARSLAVYSVIGYILGLGDRHPGNILIDRSSGHVIHIDFGFILFNAPGRFPFPEK 1984
                          890       900       910       920       930       940       950       960
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  871 IPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHRDSVMAVLEAFVYDPLLNWRLMdtntkgtkrsrtrtdsysagqs 950
Cdd:COG5032   1985 VPFRLTRNIVEAMGVSGVEGSFRELCETAFRALRKNADSLMNVLELFVRDPLIEWRRL---------------------- 2042
                          970       980       990      1000      1010      1020      1030      1040
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  951 vetmegidlgetthkkpgttvPESihsfigdglvqPEALNKKAIQIINRVRDKLTGRDFSHDETLDVPTQVELLIKQATS 1030
Cdd:COG5032   2043 ---------------------PCF-----------REIQNNEIVNVLERFRLKLSEKDAEKFVDLLINKSVESLITQATD 2090
                         1050
                   ....*....|...
gi 1878422027 1031 HENLCQCYIGCMA 1043
Cdd:COG5032   2091 PFQLATMYIGWMP 2103
FAT pfam02259
FAT domain; The FAT domain is named after FRAP, ATM and TRRAP.
31-404 9.35e-120

FAT domain; The FAT domain is named after FRAP, ATM and TRRAP.


Pssm-ID: 396714 [Multi-domain]  Cd Length: 342  Bit Score: 381.70  E-value: 9.35e-120
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027   31 WGLGHWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCQMLSELE 110
Cdd:pfam02259    9 WRLGQWDLMREYLSLMKKDSPDKAFFEAILALHRNQFDEAERYIEKARQLLDTELSALSGESYNRAYPLLVRLQQLAELE 88
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  111 EVIQYKL----VPERRDIIRETWWERLQGCQRIVEDWQRILMVRSLVINPHED-------MRTWLKYASLCGKSGRLALA 179
Cdd:pfam02259   89 EIIQYKQklgqSSEELKSLLQTWRNRLPGCQDDVEIWQDILTVRSLVLSPIEDvylggyhAEMWLKFANLARKSGRFSLA 168
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  180 HKTLVLLLGVDPskqldqplPTAHPHVTYAYMKYMWKSARKIEAFQHMQHFVQAMQQKA---QHAIAAEDQQQKQELHKL 256
Cdd:pfam02259  169 EKALLKLLGEDP--------EEWLPEVVYAYAKYLWPTGEQQEALLKLREFLSCYLQKNgelLSGLEVINPTNLEEFTEL 240
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  257 MARCFLKLGEWQLSLQ-GINESTIPKVLQYYSHSTEHDRNWYKAWHAWAVMNFEAVLHYKHQNQgrdekkklrhasgasg 335
Cdd:pfam02259  241 LARCYLLKGKWQAALGqNWAEEKSEEILQAYLLATQFDPSWYKAWHTWALFNFEVLRKEEQGKE---------------- 304
                          330       340       350       360       370       380
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1878422027  336 asanseasnsdseadsadhspvpspgqkkvnEDLSKTLLLYTVPAVQGFFRSISLSRGNNLQDTLRVLT 404
Cdd:pfam02259  305 -------------------------------EEGPEDLSRYVVPAVEGYLRSLSLSSENSLQDTLRLLT 342
Rrp6p_like_exo cd06147
DEDDy 3'-5' exonuclease domain of yeast Rrp6p, human polymyositis/scleroderma autoantigen ...
1296-1485 5.25e-116

DEDDy 3'-5' exonuclease domain of yeast Rrp6p, human polymyositis/scleroderma autoantigen 100kDa, and similar proteins; Yeast Rrp6p and its human homolog, the polymyositis/scleroderma autoantigen 100kDa (PM/Scl-100), are exosome-associated proteins involved in the degradation and processing of precursors to stable RNAs. Both proteins contain a DEDDy-type DnaQ-like 3'-5' exonuclease domain possessing three conserved sequence motifs termed ExoI, ExoII and ExoIII, with a specific YX(3)D pattern at ExoIII. The motifs are clustered around the active site and contain four conserved acidic residues that serve as ligands for the two metal ions required for catalysis. PM/Scl-100, an autoantigen present in the nucleolar compartment of the cell, reacts with autoantibodies produced by about 50% of patients with polymyositis-scleroderma overlap syndrome.


Pssm-ID: 99850 [Multi-domain]  Cd Length: 192  Bit Score: 364.61  E-value: 5.25e-116
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1296 ETNCQFISSLEDLAALNEKLNQTTEFAVDLEHHSYRSFLGITCLMQISTREEDFIIDTLELRSEMYVLNESFTNPSIVKV 1375
Cdd:cd06147      2 ETPLTFVDTEEKLEELVEKLKNCKEIAVDLEHHSYRSYLGFTCLMQISTREEDYIVDTLKLRDDMHILNEVFTDPNILKV 81
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1376 FHGADSDIEWLQKDFGLYVVNMFDTHQASRSLNLGRNSLDHLLKVFCNVDSNKRFQLADWRIRPLPEEMIKYAQADTHYL 1455
Cdd:cd06147     82 FHGADSDIIWLQRDFGLYVVNLFDTGQAARVLNLPRHSLAYLLQKYCNVDADKKYQLADWRIRPLPEEMIKYAREDTHYL 161
                          170       180       190
                   ....*....|....*....|....*....|.
gi 1878422027 1456 LYVYDRLRADLFDAAN-GQPALIQLVWSKSK 1485
Cdd:cd06147    162 LYIYDRLRNELLERANaLAPNLLESVLNCSR 192
PI3_PI4_kinase pfam00454
Phosphatidylinositol 3- and 4-kinase; Some members of this family probably do not have lipid ...
680-927 6.60e-95

Phosphatidylinositol 3- and 4-kinase; Some members of this family probably do not have lipid kinase activity and are protein kinases,.


Pssm-ID: 395364 [Multi-domain]  Cd Length: 241  Bit Score: 306.56  E-value: 6.60e-95
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  680 FLLKGHEDLRQDERVMQLFGLVNTLLANDPASLRKnlsIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKkILLNI 759
Cdd:pfam00454    4 GIYKVGDDLRQDELILQVFKLMDEELSKDNLDLRR---LKPYSVIPLGPKCGIIEWVPNSETLAYILDEYGENG-VPPTA 79
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  760 EHRIMlRMAPDYDHLTLMekvevFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSN 839
Cdd:pfam00454   80 MVKIL-HSALNYPKLKLE-----FESRISLPPKVGLLQWFVKKSPDAEEWGEARKNFVRSCAGYSVLDYILGNGDRHLDN 153
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  840 LMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHRDSVMAVLEAFVY 919
Cdd:pfam00454  154 ILVDKTTGKLFHIDFGLCLPDAGKDLPFPEKVPFRLTREMVYAMGPSGDEGLFRELCETAYEALRRNLNLLTNLLKLMVA 233

                   ....*...
gi 1878422027  920 DPLLNWRL 927
Cdd:pfam00454  234 DGLPDWSI 241
PI3Kc smart00146
Phosphoinositide 3-kinase, catalytic domain; Phosphoinositide 3-kinase isoforms participate in ...
680-929 1.17e-91

Phosphoinositide 3-kinase, catalytic domain; Phosphoinositide 3-kinase isoforms participate in a variety of processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, and apoptosis. These homologues may be either lipid kinases and/or protein kinases: the former phosphorylate the 3-position in the inositol ring of inositol phospholipids. The ataxia telangiectesia-mutated gene produced, the targets of rapamycin (TOR) and the DNA-dependent kinase have not been found to possess lipid kinase activity. Some of this family possess PI-4 kinase activities.


Pssm-ID: 214538 [Multi-domain]  Cd Length: 240  Bit Score: 297.29  E-value: 1.17e-91
                            10        20        30        40        50        60        70        80
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027   680 FLLKGHEDLRQDERVMQLFGLVNTLLANDPASLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKIllni 759
Cdd:smart00146    1 VIFKGGDDLRQDERVLQLLRLMNKLLQKDKETRRRDLHLRPYKVIPTGPKSGLIEVVPNSTTLHEILKEYRKQKGK---- 76
                            90       100       110       120       130       140       150       160
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027   760 ehrimlRMAPDYDHLTLMEKVEVFEHAVNNTAGDDLAKLLWLKSPS-SEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPS 838
Cdd:smart00146   77 ------VLDLRSQTATRLKKLELFLEATGKFPDPVLYDWFTKKFPDpSEDYFEARKNFTRSCAGYSVITYILGLGDRHND 150
                           170       180       190       200       210       220       230       240
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027   839 NLMLDRlSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHRDSVMAVLEAFV 918
Cdd:smart00146  151 NIMLDK-TGHLFHIDFGFILGNGPKLFGFPERVPFRLTPEMVDVMGDSGYFGLFRSLCERALRALRKNSNLIMSLLELML 229
                           250
                    ....*....|.
gi 1878422027   919 YDPLLNWRLMD 929
Cdd:smart00146  230 YDGLPDWRSGK 240
DNA_pol_A_exo1 pfam01612
3'-5' exonuclease; This domain is responsible for the 3'-5' exonuclease proofreading activity ...
1299-1466 1.17e-53

3'-5' exonuclease; This domain is responsible for the 3'-5' exonuclease proofreading activity of E. coli DNA polymerase I (polI) and other enzymes, it catalyzes the hydrolysis of unpaired or mismatched nucleotides. This domain consists of the amino-terminal half of the Klenow fragment in E. coli polI it is also found in the Werner syndrome helicase (WRN), focus forming activity 1 protein (FFA-1) and ribonuclease D (RNase D). Werner syndrome is a human genetic disorder causing premature aging; the WRN protein has helicase activity in the 3'-5' direction. The FFA-1 protein is required for formation of a replication foci and also has helicase activity; it is a homolog of the WRN protein. RNase D is a 3'-5' exonuclease involved in tRNA processing. Also found in this family is the autoantigen PM/Scl thought to be involved in polymyositis-scleroderma overlap syndrome.


Pssm-ID: 396266 [Multi-domain]  Cd Length: 173  Bit Score: 185.58  E-value: 1.17e-53
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1299 CQFISSLEDLAALNEKLNQTTEFAVDLEHHSYR--SFLGITCLMQISTREEDFIIDTLELRSE-MYVLNESFTNPSIVKV 1375
Cdd:pfam01612    1 YRIVTTEDELEDLIEELLNAPYVAVDTETTSLDtySYYLRGALIQIGTGEGAYIIDPLALGDDvLSALKRLLEDPNITKV 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1376 FHGADSDIEWLQKDFGLYVVNMFDTHQASRSLNLGRN-SLDHLLKVFCNVDSNKRFQLADWRIRPLPEEMIKYAQADTHY 1454
Cdd:pfam01612   81 GHNAKFDLEVLARDFGIKLRNLFDTMLAAYLLGYDRShSLADLAEKYLGVELDKEEQCSDWQARPLSEEQLRYAALDADY 160
                          170
                   ....*....|..
gi 1878422027 1455 LLYVYDRLRADL 1466
Cdd:pfam01612  161 LLRLYDKLRKEL 172
Rnd COG0349
Ribonuclease D [Translation, ribosomal structure and biogenesis];
1301-1591 1.99e-53

Ribonuclease D [Translation, ribosomal structure and biogenesis];


Pssm-ID: 440118 [Multi-domain]  Cd Length: 365  Bit Score: 192.01  E-value: 1.99e-53
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1301 FISSLEDLAALNEKLNQTTEFAVDLEHHSYRSFLGITCLMQISTREEDFIIDTLELrSEMYVLNESFTNPSIVKVFHGAD 1380
Cdd:COG0349      1 LITTDEELAALCARLAQAPAVAVDTEFMRERTYYPRLCLIQLADGEEVALIDPLAI-GDLSPLWELLADPAIVKVFHAAR 79
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1381 SDIEWLQKDFGLYVVNMFDTHQASRSLNLGRN-SLDHLLKVFCNVDSNKRFQLADWRIRPLPEEMIKYAQADTHYLLYVY 1459
Cdd:COG0349     80 EDLEILYHLFGILPKPLFDTQIAAALLGYGDSvGYAALVEELLGVELDKSEQRSDWLRRPLSEEQLEYAAADVRYLLPLY 159
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1460 DRLRADLfdAANGQPALIQlvwSKSKDLCLKKYiKPIFTEESYLELykKQKKSFNGQQLSAFRFMYAWRDKLAREEDEST 1539
Cdd:COG0349    160 EKLLEEL--EREGRLEWAE---EECARLLDPAT-YREDPEEAWLRL--KGAWKLNPRQLAVLRELAAWREREARKRDVPR 231
                          250       260       270       280       290
                   ....*....|....*....|....*....|....*....|....*....|..
gi 1878422027 1540 GYILPNHMMMKISEELPKEPQGIIACCNPTPPLVRQQINELHQLIKQAREIP 1591
Cdd:COG0349    232 NRVLKDEALLELARRQPKSLEELARLRGLSPGEIRRHGEELLAAVAEALALP 283
35EXOc smart00474
3'-5' exonuclease; 3\' -5' exonuclease proofreading domain present in DNA polymerase I, Werner ...
1300-1466 4.34e-40

3'-5' exonuclease; 3\' -5' exonuclease proofreading domain present in DNA polymerase I, Werner syndrome helicase, RNase D and other enzymes


Pssm-ID: 214681 [Multi-domain]  Cd Length: 172  Bit Score: 146.73  E-value: 4.34e-40
                            10        20        30        40        50        60        70        80
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  1300 QFISSLEDLAALNEKL-NQTTEFAVDLEHHSYRSFLGITCLMQIS-TREEDFIIDTLELRSEMYVLNESFTNPSIVKVFH 1377
Cdd:smart00474    2 IVVTDSETLEELLEKLrAAGGEVALDTETTGLDSYSGKLVLIQISvTGEGAFIIDPLALGDDLEILKDLLEDETITKVGH 81
                            90       100       110       120       130       140       150       160
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  1378 GADSDIEWLQKdFGLYVVNMFDTHQASRSL--NLGRNSLDHLLKVFCNVDSNKRFQLADWRIRPLPEEMIKYAQADTHYL 1455
Cdd:smart00474   82 NAKFDLHVLAR-FGIELENIFDTMLAAYLLlgGPSKHGLATLLLGYLGVELDKEEQKSDWGARPLSEEQLEYAAEDADAL 160
                           170
                    ....*....|.
gi 1878422027  1456 LYVYDRLRADL 1466
Cdd:smart00474  161 LRLYEKLEKEL 171
PMC2NT pfam08066
PMC2NT (NUC016) domain; This domain is found at the N-terminus of 3'-5' exonucleases with HRDC ...
1089-1178 8.80e-28

PMC2NT (NUC016) domain; This domain is found at the N-terminus of 3'-5' exonucleases with HRDC domains, and also in putative exosome components.


Pssm-ID: 462352  Cd Length: 89  Bit Score: 108.42  E-value: 8.80e-28
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1089 VGATKASAGLPqaGDEYDFYRSF-PGFQDFCAVQGDRILHCMSQLMQHHGCRSHLRDRNKLTGLEERFDMVVDANDAILE 1167
Cdd:pfam08066    1 VSTTRAANALP--AQDIDFYRSLdPEFAESLDEQSARLLSLINSLLQSAGSKSNIKAPGDLDDVEDRWDSVVDVNDSLLE 78
                           90
                   ....*....|.
gi 1878422027 1168 KVGILLDEASG 1178
Cdd:pfam08066   79 KADICLDELTG 89
rnd TIGR01388
ribonuclease D; This model describes ribonuclease D, a 3'-exonuclease shown to act on tRNA ...
1302-1591 1.05e-26

ribonuclease D; This model describes ribonuclease D, a 3'-exonuclease shown to act on tRNA both in vitro and when overexpressed in vivo. Trusted members of this family are restricted to the Proteobacteria; Aquifex, Mycobacterial, and eukaryotic homologs are not full-length homologs. Ribonuclease D is not essential in E. coli and is deleterious when overexpressed. Its precise biological role is still unknown. [Transcription, RNA processing]


Pssm-ID: 130455 [Multi-domain]  Cd Length: 367  Bit Score: 114.10  E-value: 1.05e-26
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1302 ISSLEDLAALNEKLNQTTEFAVDLEHHSYRSFLGITCLMQISTREEDFIIDTLELrSEMYVLNESFTNPSIVKVFHGADS 1381
Cdd:TIGR01388    2 ITTDDELATVCEAVRTFPFVALDTEFVRERTFWPQLGLIQVADGEQLALIDPLVI-IDWSPLKELLRDESVVKVLHAASE 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1382 DIEWLQKDFGLYVVNMFDTHQASRSLNLGRN-SLDHLLKVFCNVDSNKRFQLADWRIRPLPEEMIKYAQADTHYLLYVYD 1460
Cdd:TIGR01388   81 DLEVFLNLFGELPQPLFDTQIAAAFCGFGMSmGYAKLVQEVLGVELDKSESRTDWLARPLTDAQLEYAAADVTYLLPLYA 160
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1461 RLRADLfDAANGQPALIQlvwskSKDLCLKKYIKPIFTEESYLELYKKQKksFNGQQLSAFRFMYAWRDKLAREEDESTG 1540
Cdd:TIGR01388  161 KLMERL-EESGRLAWLEE-----ECTLLTDRRTYVVNPEDAWRDIKNAWQ--LRPQQLAVLQALAAWREREARERDLPRN 232
                          250       260       270       280       290
                   ....*....|....*....|....*....|....*....|....*....|.
gi 1878422027 1541 YILPNHMMMKISEELPKEPqGIIACCNPTPPLVRQQINELHQLIKQAREIP 1591
Cdd:TIGR01388  233 FVLKEEALWELARQAPGNL-TELASLGPKGSEIRKHGDTLLALVKTALALP 282
HRDC smart00341
Helicase and RNase D C-terminal; Hypothetical role in nucleic acid binding. Mutations in the ...
1516-1594 3.52e-16

Helicase and RNase D C-terminal; Hypothetical role in nucleic acid binding. Mutations in the HRDC domain cause human disease.


Pssm-ID: 128635 [Multi-domain]  Cd Length: 81  Bit Score: 75.03  E-value: 3.52e-16
                            10        20        30        40        50        60        70
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1878422027  1516 QQLSAFRFMYAWRDKLAREEDESTGYILPNHMMMKISEELPKEPQGIIACCNPTPPLVRQQINELHQLIKQAREIPLLK 1594
Cdd:smart00341    3 RQLRLLRRLRQWRDEIARREDVPPYFVLPDETLIKMAAALPTNVSELLAIDGVGEEKARRYGKDLLAVIQEASDSPSEA 81
HRDC pfam00570
HRDC domain; The HRDC (Helicase and RNase D C-terminal) domain has a putative role in nucleic ...
1517-1584 5.27e-14

HRDC domain; The HRDC (Helicase and RNase D C-terminal) domain has a putative role in nucleic acid binding. Mutations in the HRDC domain cause human disease. It is interesting to note that the RecQ helicase in Deinococcus radiodurans has three tandem HRDC domains.


Pssm-ID: 425755 [Multi-domain]  Cd Length: 68  Bit Score: 68.33  E-value: 5.27e-14
                           10        20        30        40        50        60
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1878422027 1517 QLSAFRFMYAWRDKLAREEDESTGYILPNHMMMKISEELPKEPQGIIACCNPTPPLVRQQINELHQLI 1584
Cdd:pfam00570    1 QLALLKALREWRDELAREEDVPPYVIFPDKTLLEIAEKLPRTLEELLAIPGVGPRKVERYGEEILAAI 68
PRK10829 PRK10829
ribonuclease D; Provisional
1298-1536 9.57e-13

ribonuclease D; Provisional


Pssm-ID: 236771 [Multi-domain]  Cd Length: 373  Bit Score: 71.96  E-value: 9.57e-13
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1298 NCQFISSLEDLAALNEKLNQTTEFAVDLEHHSYRSF---LGitcLMQISTREEDFIIDTLELrSEMYVLNESFTNPSIVK 1374
Cdd:PRK10829     2 NYQMITTDDALASVCEAARAFPAIALDTEFVRTRTYypqLG---LIQLYDGEQLSLIDPLGI-TDWSPFKALLRDPQVTK 77
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1375 VFHGADSDIEWLQKDFGLYVVNMFDTHQAS----RSLNLGRNSLdhlLKVFCNVDSNKRFQLADWRIRPLPEEMIKYAQA 1450
Cdd:PRK10829    78 FLHAGSEDLEVFLNAFGELPQPLIDTQILAafcgRPLSCGFASM---VEEYTGVTLDKSESRTDWLARPLSERQCEYAAA 154
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1451 DTHYLLYVYDRLRADLfdAANGQpaliqlvWSKSKDLCL------KKYIKPiftEESYLELYKKQKksFNGQQLSAFRFM 1524
Cdd:PRK10829   155 DVFYLLPIAAKLMAET--EAAGW-------LPAALDECRllcqrrQEVLAP---EEAYRDITNAWQ--LRTRQLACLQLL 220
                          250
                   ....*....|..
gi 1878422027 1525 YAWRDKLAREED 1536
Cdd:PRK10829   221 ADWRLRKARERD 232
 
Name Accession Description Interval E-value
PIKKc_TOR cd05169
Catalytic domain of Target of Rapamycin; TOR contains a rapamycin binding domain, a catalytic ...
649-927 0e+00

Catalytic domain of Target of Rapamycin; TOR contains a rapamycin binding domain, a catalytic domain, and a FATC (FRAP, ATM and TRRAP, C-terminal) domain at the C-terminus. It is also called FRAP (FK506 binding protein 12-rapamycin associated protein). TOR is a central component of the eukaryotic growth regulatory network. It controls the expression of many genes transcribed by all three RNA polymerases. It associates with other proteins to form two distinct complexes, TORC1 and TORC2. TORC1 is involved in diverse growth-related functions including protein synthesis, nutrient use and transport, autophagy and stress responses. TORC2 is involved in organizing cytoskeletal structures. TOR is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). The TOR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270713 [Multi-domain]  Cd Length: 279  Bit Score: 619.50  E-value: 0e+00
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  649 IQSIAPSLQVITSKQRPRKLTIMGSNGHEFMFLLKGHEDLRQDERVMQLFGLVNTLLANDPASLRKNLSIQRYAVIPLST 728
Cdd:cd05169      1 ISSFDPTLEVITSKQRPRKLTIVGSDGKEYKFLLKGHEDLRLDERVMQLFGLVNTLLKNDSETSRRNLSIQRYSVIPLSP 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  729 NSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMEKVEVFEHAVNNTAGDDLAKLLWLKSPSSEV 808
Cdd:cd05169     81 NSGLIGWVPGCDTLHSLIRDYREKRKIPLNIEHRLMLQMAPDYDNLTLIQKVEVFEYALENTPGDDLRRVLWLKSPSSEA 160
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  809 WFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGL 888
Cdd:cd05169    161 WLERRTNFTRSLAVMSMVGYILGLGDRHPSNIMLDRLTGKVIHIDFGDCFEVAMHREKFPEKVPFRLTRMLVNAMEVSGV 240
                          250       260       270
                   ....*....|....*....|....*....|....*....
gi 1878422027  889 DGNYRITCHTVMEVLREHRDSVMAVLEAFVYDPLLNWRL 927
Cdd:cd05169    241 EGTFRSTCEDVMRVLRENKDSLMAVLEAFVHDPLISWRL 279
TEL1 COG5032
Phosphatidylinositol kinase or protein kinase, PI-3 family [Signal transduction mechanisms];
31-1043 1.28e-176

Phosphatidylinositol kinase or protein kinase, PI-3 family [Signal transduction mechanisms];


Pssm-ID: 227365 [Multi-domain]  Cd Length: 2105  Bit Score: 589.83  E-value: 1.28e-176
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027   31 WGLGHWDSMEEYTCMIPRDTHDGAFY--RAVLALHQDLFslaqQCIDK-----ARDLLDAELTAMA-GESYSRAYGAMVS 102
Cdd:COG5032   1161 EQVGEWYKAQQLYEVAQRKARSKEFPfsLQYLYWHINDI----DCADKlqsvlAELSLVTGISELLlEESWRRALFSNIK 1236
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  103 CQMLSELEEVI--QYKLVPE-----RRDIIRETWWERLQG---CQRIVEDWQRILMVRSLVINPHEDMRTWLKYASLCGK 172
Cdd:COG5032   1237 DSLESELEEIIdgMYKSNEDfgalmLLSLSAELWDKILEGrssCSKSIKLSLNIWLDLSIVVSPKDEPELFIKFVELCEA 1316
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  173 SG-RLALAHKTLVLLLG---VDPSKqLDQPLPTAHPHVTYAYMKYMWKSARKIEAFQHMQHF----VQAMQQKAQHAIAA 244
Cdd:COG5032   1317 SSiRSKLLEKNIQELLEkleEIKSP-LGTLRDRLPPPWALLDLKRLLATWRQNAFLRINPELlpllSSLLNLQSSSLSKQ 1395
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  245 EDQQQKQE-------LHKLMARCFLKLGEWQLSLQ-GINESTIPKVLQYYSHSTEHDRNWYKAWHA-WAVMNFEAVLHYK 315
Cdd:COG5032   1396 LVSRGSSEsaisinsFASVARKHFLPDNQLKKIYQlSNILISEAFLLLRYLLLCRLGRRELKAGLNvWNLTNLELFSDIQ 1475
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  316 hqnqgrdekkklrhasgasgasanseasnsdseadsadhspvpspgQKKVNEDLSKTLLLYTVPAVQGFFRSISLSRGNN 395
Cdd:COG5032   1476 ----------------------------------------------ESEFFEWGKNLKLLSIIPPIEEIFLSNALSCYLQ 1509
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  396 LQDTLRVLTLWFDYGHWPEVNEALVEGIKTIQIDT-WLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTV 474
Cdd:COG5032   1510 VKDLLKKLNLFELLGSLLSAKDAAGSYYKNFHIFDlEISVIPFIPQLLSSLSLLDLNSAQSLLSKIGKEHPQALVFTLRS 1589
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  475 ASKSTTTARHNAANKILKNMCEHCNTLVQQAIMVSEELIR-VAILWHEMWHEGLEEASRLYFGERN-VKGMFAVLEPLHA 552
Cdd:COG5032   1590 AIESTALSKESVALSLENKSRTHDPSLVKEALELSDENIRiAYPLLHLLFEPILAQLLSRLSSENNkISVALLIDKPLHE 1669
                          570       580       590       600       610       620       630       640
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  553 MMERGPQTLKETSFNQAYGRDLMEAQDWCRKYMRSGNVKDLTQAWDLYYHVFRRIAKQLPQLTSLELQYVSPKLL-MCRD 631
Cdd:COG5032   1670 ERENFPSGLSLSSFQSSFLKELIKKSPRKIRKKFKIDISLLNLSRKLYISVLRSIRKRLKRLLELRLKKVSPKLLlFHAF 1749
                          650       660       670       680       690       700       710       720
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  632 LELAVPGTYDPNQPIIRIQSIAPSLQVITS-KQRPRKLTIMGSNGHEFMFLLKGHEDLRQDERVMQLFGLVNTLLANDPA 710
Cdd:COG5032   1750 LEIKLPGQYLLDKPFVLIERFEPEVSVVKShLQRPRRLTIRGSDGKLYSFIVKGGDDLRQDELALQLIRLMNKILKKDKE 1829
                          730       740       750       760       770       780       790       800
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  711 SLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRimlrMAPDYDHLTLMEKVEVFEHAVNNT 790
Cdd:COG5032   1830 TRRRDLWIRPYKVIPLSPGSGIIEWVPNSDTLHSILREYHKRKNISIDQEKK----LAARLDNLKLLLKDEFFTKATLKS 1905
                          810       820       830       840       850       860       870       880
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  791 AgDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEK 870
Cdd:COG5032   1906 P-PVLYDWFSESFPNPEDWLTARTNFARSLAVYSVIGYILGLGDRHPGNILIDRSSGHVIHIDFGFILFNAPGRFPFPEK 1984
                          890       900       910       920       930       940       950       960
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  871 IPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHRDSVMAVLEAFVYDPLLNWRLMdtntkgtkrsrtrtdsysagqs 950
Cdd:COG5032   1985 VPFRLTRNIVEAMGVSGVEGSFRELCETAFRALRKNADSLMNVLELFVRDPLIEWRRL---------------------- 2042
                          970       980       990      1000      1010      1020      1030      1040
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  951 vetmegidlgetthkkpgttvPESihsfigdglvqPEALNKKAIQIINRVRDKLTGRDFSHDETLDVPTQVELLIKQATS 1030
Cdd:COG5032   2043 ---------------------PCF-----------REIQNNEIVNVLERFRLKLSEKDAEKFVDLLINKSVESLITQATD 2090
                         1050
                   ....*....|...
gi 1878422027 1031 HENLCQCYIGCMA 1043
Cdd:COG5032   2091 PFQLATMYIGWMP 2103
FAT pfam02259
FAT domain; The FAT domain is named after FRAP, ATM and TRRAP.
31-404 9.35e-120

FAT domain; The FAT domain is named after FRAP, ATM and TRRAP.


Pssm-ID: 396714 [Multi-domain]  Cd Length: 342  Bit Score: 381.70  E-value: 9.35e-120
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027   31 WGLGHWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCQMLSELE 110
Cdd:pfam02259    9 WRLGQWDLMREYLSLMKKDSPDKAFFEAILALHRNQFDEAERYIEKARQLLDTELSALSGESYNRAYPLLVRLQQLAELE 88
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  111 EVIQYKL----VPERRDIIRETWWERLQGCQRIVEDWQRILMVRSLVINPHED-------MRTWLKYASLCGKSGRLALA 179
Cdd:pfam02259   89 EIIQYKQklgqSSEELKSLLQTWRNRLPGCQDDVEIWQDILTVRSLVLSPIEDvylggyhAEMWLKFANLARKSGRFSLA 168
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  180 HKTLVLLLGVDPskqldqplPTAHPHVTYAYMKYMWKSARKIEAFQHMQHFVQAMQQKA---QHAIAAEDQQQKQELHKL 256
Cdd:pfam02259  169 EKALLKLLGEDP--------EEWLPEVVYAYAKYLWPTGEQQEALLKLREFLSCYLQKNgelLSGLEVINPTNLEEFTEL 240
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  257 MARCFLKLGEWQLSLQ-GINESTIPKVLQYYSHSTEHDRNWYKAWHAWAVMNFEAVLHYKHQNQgrdekkklrhasgasg 335
Cdd:pfam02259  241 LARCYLLKGKWQAALGqNWAEEKSEEILQAYLLATQFDPSWYKAWHTWALFNFEVLRKEEQGKE---------------- 304
                          330       340       350       360       370       380
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1878422027  336 asanseasnsdseadsadhspvpspgqkkvnEDLSKTLLLYTVPAVQGFFRSISLSRGNNLQDTLRVLT 404
Cdd:pfam02259  305 -------------------------------EEGPEDLSRYVVPAVEGYLRSLSLSSENSLQDTLRLLT 342
Rrp6p_like_exo cd06147
DEDDy 3'-5' exonuclease domain of yeast Rrp6p, human polymyositis/scleroderma autoantigen ...
1296-1485 5.25e-116

DEDDy 3'-5' exonuclease domain of yeast Rrp6p, human polymyositis/scleroderma autoantigen 100kDa, and similar proteins; Yeast Rrp6p and its human homolog, the polymyositis/scleroderma autoantigen 100kDa (PM/Scl-100), are exosome-associated proteins involved in the degradation and processing of precursors to stable RNAs. Both proteins contain a DEDDy-type DnaQ-like 3'-5' exonuclease domain possessing three conserved sequence motifs termed ExoI, ExoII and ExoIII, with a specific YX(3)D pattern at ExoIII. The motifs are clustered around the active site and contain four conserved acidic residues that serve as ligands for the two metal ions required for catalysis. PM/Scl-100, an autoantigen present in the nucleolar compartment of the cell, reacts with autoantibodies produced by about 50% of patients with polymyositis-scleroderma overlap syndrome.


Pssm-ID: 99850 [Multi-domain]  Cd Length: 192  Bit Score: 364.61  E-value: 5.25e-116
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1296 ETNCQFISSLEDLAALNEKLNQTTEFAVDLEHHSYRSFLGITCLMQISTREEDFIIDTLELRSEMYVLNESFTNPSIVKV 1375
Cdd:cd06147      2 ETPLTFVDTEEKLEELVEKLKNCKEIAVDLEHHSYRSYLGFTCLMQISTREEDYIVDTLKLRDDMHILNEVFTDPNILKV 81
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1376 FHGADSDIEWLQKDFGLYVVNMFDTHQASRSLNLGRNSLDHLLKVFCNVDSNKRFQLADWRIRPLPEEMIKYAQADTHYL 1455
Cdd:cd06147     82 FHGADSDIIWLQRDFGLYVVNLFDTGQAARVLNLPRHSLAYLLQKYCNVDADKKYQLADWRIRPLPEEMIKYAREDTHYL 161
                          170       180       190
                   ....*....|....*....|....*....|.
gi 1878422027 1456 LYVYDRLRADLFDAAN-GQPALIQLVWSKSK 1485
Cdd:cd06147    162 LYIYDRLRNELLERANaLAPNLLESVLNCSR 192
PIKKc cd05164
Catalytic domain of Phosphoinositide 3-kinase-related protein kinases; PIKK subfamily members ...
649-920 1.81e-101

Catalytic domain of Phosphoinositide 3-kinase-related protein kinases; PIKK subfamily members include ATM (Ataxia telangiectasia mutated), ATR (Ataxia telangiectasia and Rad3-related), TOR (Target of rapamycin), SMG-1 (Suppressor of morphogenetic effect on genitalia-1), and DNA-PK (DNA-dependent protein kinase). PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). They show strong preference for phosphorylating serine/threonine residues followed by a glutamine and are also referred to as (S/T)-Q-directed kinases. They all contain a FATC (FRAP, ATM and TRRAP, C-terminal) domain. PIKKs have diverse functions including cell-cycle checkpoints, genome surveillance, mRNA surveillance, and translation control. The PIKK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270708 [Multi-domain]  Cd Length: 222  Bit Score: 324.61  E-value: 1.81e-101
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  649 IQSIAPSLQVITSKQRPRKLTIMGSNGHEFMFLLKGHEDLRQDERVMQLFGLVNTLLANDPASLRKNLSIQRYAVIPLST 728
Cdd:cd05164      1 IASFDPRVRILASLQKPKKITILGSDGKEYPFLVKGDDDLRKDERVMQLFQLLNTLLEKDKETRKRNLTIRTYSVVPLSS 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  729 NSGLIGWVPHCDTLHalirdyrekkkillniehrimlrmapdydhltlmekvevfehavnntagDDLAKLLWLKSPSSEV 808
Cdd:cd05164     81 QSGLIEWVDNTTTLK-------------------------------------------------PVLKKWFNETFPDPTQ 111
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  809 WFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKfPEKIPFRLTRMLTNAMEVTGL 888
Cdd:cd05164    112 WYEARSNYTKSTAVMSMVGYIIGLGDRHLENILIDTKTGEVVHIDFGMIFNKGKTLPV-PEIVPFRLTRNIINGMGPTGV 190
                          250       260       270
                   ....*....|....*....|....*....|..
gi 1878422027  889 DGNYRITCHTVMEVLREHRDSVMAVLEAFVYD 920
Cdd:cd05164    191 EGLFRKSCEQVLRVFRKHKDKLITFLDTFLYD 222
PI3_PI4_kinase pfam00454
Phosphatidylinositol 3- and 4-kinase; Some members of this family probably do not have lipid ...
680-927 6.60e-95

Phosphatidylinositol 3- and 4-kinase; Some members of this family probably do not have lipid kinase activity and are protein kinases,.


Pssm-ID: 395364 [Multi-domain]  Cd Length: 241  Bit Score: 306.56  E-value: 6.60e-95
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  680 FLLKGHEDLRQDERVMQLFGLVNTLLANDPASLRKnlsIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKkILLNI 759
Cdd:pfam00454    4 GIYKVGDDLRQDELILQVFKLMDEELSKDNLDLRR---LKPYSVIPLGPKCGIIEWVPNSETLAYILDEYGENG-VPPTA 79
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  760 EHRIMlRMAPDYDHLTLMekvevFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSN 839
Cdd:pfam00454   80 MVKIL-HSALNYPKLKLE-----FESRISLPPKVGLLQWFVKKSPDAEEWGEARKNFVRSCAGYSVLDYILGNGDRHLDN 153
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  840 LMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHRDSVMAVLEAFVY 919
Cdd:pfam00454  154 ILVDKTTGKLFHIDFGLCLPDAGKDLPFPEKVPFRLTREMVYAMGPSGDEGLFRELCETAYEALRRNLNLLTNLLKLMVA 233

                   ....*...
gi 1878422027  920 DPLLNWRL 927
Cdd:pfam00454  234 DGLPDWSI 241
PI3Kc smart00146
Phosphoinositide 3-kinase, catalytic domain; Phosphoinositide 3-kinase isoforms participate in ...
680-929 1.17e-91

Phosphoinositide 3-kinase, catalytic domain; Phosphoinositide 3-kinase isoforms participate in a variety of processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, and apoptosis. These homologues may be either lipid kinases and/or protein kinases: the former phosphorylate the 3-position in the inositol ring of inositol phospholipids. The ataxia telangiectesia-mutated gene produced, the targets of rapamycin (TOR) and the DNA-dependent kinase have not been found to possess lipid kinase activity. Some of this family possess PI-4 kinase activities.


Pssm-ID: 214538 [Multi-domain]  Cd Length: 240  Bit Score: 297.29  E-value: 1.17e-91
                            10        20        30        40        50        60        70        80
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027   680 FLLKGHEDLRQDERVMQLFGLVNTLLANDPASLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKIllni 759
Cdd:smart00146    1 VIFKGGDDLRQDERVLQLLRLMNKLLQKDKETRRRDLHLRPYKVIPTGPKSGLIEVVPNSTTLHEILKEYRKQKGK---- 76
                            90       100       110       120       130       140       150       160
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027   760 ehrimlRMAPDYDHLTLMEKVEVFEHAVNNTAGDDLAKLLWLKSPS-SEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPS 838
Cdd:smart00146   77 ------VLDLRSQTATRLKKLELFLEATGKFPDPVLYDWFTKKFPDpSEDYFEARKNFTRSCAGYSVITYILGLGDRHND 150
                           170       180       190       200       210       220       230       240
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027   839 NLMLDRlSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHRDSVMAVLEAFV 918
Cdd:smart00146  151 NIMLDK-TGHLFHIDFGFILGNGPKLFGFPERVPFRLTPEMVDVMGDSGYFGLFRSLCERALRALRKNSNLIMSLLELML 229
                           250
                    ....*....|.
gi 1878422027   919 YDPLLNWRLMD 929
Cdd:smart00146  230 YDGLPDWRSGK 240
PIKKc_ATR cd00892
Catalytic domain of Ataxia telangiectasia and Rad3-related proteins; ATR is also referred to ...
649-926 2.15e-87

Catalytic domain of Ataxia telangiectasia and Rad3-related proteins; ATR is also referred to as Mei-41 (Drosophila), Esr1/Mec1p (Saccharomyces cerevisiae), Rad3 (Schizosaccharomyces pombe), and FRAP-related protein (human). ATR contains a UME domain of unknown function, a FAT (FRAP, ATM and TRRAP) domain, a catalytic domain, and a FATC domain at the C-terminus. Together with its downstream effector kinase, Chk1, ATR plays a central role in regulating the replication checkpoint. ATR stabilizes replication forks by promoting the association of DNA polymerases with the fork. Preventing fork collapse is essential in preserving genomic integrity. ATR also plays a role in normal cell growth and in response to DNA damage. ATR is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). The ATR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270625 [Multi-domain]  Cd Length: 237  Bit Score: 285.17  E-value: 2.15e-87
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  649 IQSIAPSLQVITSKQRPRKLTIMGSNGHEFMFLLKGHEDLRQDERVMQLFGLVNTLLANDPASLRKNLSIQRYAVIPLST 728
Cdd:cd00892      1 ISGFEDEVEIMPSLQKPKKITLVGSDGKKYPFLCKPKDDLRKDARMMEFNTLINRLLSKDPESRRRNLHIRTYAVIPLNE 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  729 NSGLIGWVPHCDTLHALIRDYRekKKILlnieHRIMLRMAPDydhltlmekvevfehavnntagddlakllwlksPSSev 808
Cdd:cd00892     81 ECGIIEWVPNTVTLRSILSTLY--PPVL----HEWFLKNFPD---------------------------------PTA-- 119
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  809 WFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFgDC-FEVAMTREKfPEKIPFRLTRMLTNAMEVTG 887
Cdd:cd00892    120 WYEARNNYTRSTAVMSMVGYILGLGDRHGENILFDSTTGDVVHVDF-DClFDKGLTLEV-PERVPFRLTQNMVDAMGVTG 197
                          250       260       270
                   ....*....|....*....|....*....|....*....
gi 1878422027  888 LDGNYRITCHTVMEVLREHRDSVMAVLEAFVYDPLLNWR 926
Cdd:cd00892    198 VEGTFRRTCEVTLRVLRENRETLMSVLETFVHDPLVEWS 236
PIKKc_SMG1 cd05170
Catalytic domain of Suppressor of Morphogenetic effect on Genitalia-1; SMG-1 plays a critical ...
649-925 1.57e-85

Catalytic domain of Suppressor of Morphogenetic effect on Genitalia-1; SMG-1 plays a critical role in the mRNA surveillance mechanism known as non-sense mediated mRNA decay (NMD). NMD protects the cells from the accumulation of aberrant mRNAs with premature termination codons (PTCs) generated by genome mutations and by errors during transcription and splicing. SMG-1 phosphorylates Upf1, another central component of NMD, at the C-terminus upon recognition of PTCs. The phosphorylation/dephosphorylation cycle of Upf1 is essential for promoting NMD. In addition to its catalytic domain, SMG-1 contains a FATC (FRAP, ATM and TRRAP, C-terminal) domain at the C-terminus. SMG-1 is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). The SMG-1 catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270714  Cd Length: 304  Bit Score: 282.61  E-value: 1.57e-85
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  649 IQSIAPSLQVITSKQRPRKLTIMGSNGHEFMFLLKGHEDLRQDERVMQLFGLVNTLLANDPASLRKNLSIQRYAVIPLST 728
Cdd:cd05170      1 IQSVGSTVTVLPTKTKPKKLVFLGSDGKRYPYLFKGLEDLHLDERIMQFLSIVNAMLASDNEHRRRRYRARHYSVTPLGP 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  729 NSGLIGWVPHCDTLHALIRDYREKKKILLNIE--------HRIMLRMAPDYDHLT--LMEKV----------------EV 782
Cdd:cd05170     81 RSGLIQWVDGATPLFSLYKRWQQRRAAAQAQKnqdsgstpPPVPRPSELFYNKLKpaLKAAGirkstsrrewplevlrQV 160
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  783 FEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAm 862
Cdd:cd05170    161 LEELVAETPRDLLARELWCSSPSSAEWWRVTQRFARSLAVMSMIGYIIGLGDRHLDNILVDLSTGEVVHIDYNVCFEKG- 239
                          250       260       270       280       290       300
                   ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1878422027  863 TREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHRDSVMAVLEAFVYDPLLNW 925
Cdd:cd05170    240 KRLRVPEKVPFRLTQNIEHALGPTGVEGTFRLSCEQVLKILRKGRETLLTLLEAFVYDPLVDW 302
PI3Kc_like cd00142
Catalytic domain of Phosphoinositide 3-kinase and similar proteins; Members of the family ...
649-920 1.10e-81

Catalytic domain of Phosphoinositide 3-kinase and similar proteins; Members of the family include PI3K, phosphoinositide 4-kinase (PI4K), PI3K-related protein kinases (PIKKs), and TRansformation/tRanscription domain-Associated Protein (TRAPP). PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives, while PI4K catalyze the phosphorylation of the 4-hydroxyl of PtdIns. PIKKs are protein kinases that catalyze the phosphorylation of serine/threonine residues, especially those that are followed by a glutamine. PI3Ks play an important role in a variety of fundamental cellular processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, immune cell activation and apoptosis. PI4Ks produce PtdIns(4)P, the major precursor to important signaling phosphoinositides. PIKKs have diverse functions including cell-cycle checkpoints, genome surveillance, mRNA surveillance, and translation control. The PI3K-like catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270621 [Multi-domain]  Cd Length: 216  Bit Score: 267.66  E-value: 1.10e-81
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  649 IQSIAPSLQVITSKQRPRKLTIMGSNGHEFMFLLKGHEDLRQDERVMQLFGLVNTLLANDpaslRKNLSIQRYAVIPLST 728
Cdd:cd00142      1 NALDVGILKVIHSKQRPKKITLIGADGKTYSFLLKRRDDLRKDERSFQFMRLIQSILEKE----SVNLVLPPYKVIPLSE 76
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  729 NSGLIGWVPHCDTLHalirdyrekkkillniehrimlrmapdydhltlmekvevfehavnntagdDLAKLLWLKSPSSEV 808
Cdd:cd00142     77 NSGLIEIVKDAQTIE--------------------------------------------------DLLKSLWRKSPSSQS 106
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  809 WFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRlSGKILHIDFGDCFEVAMTREKFpEKIPFRLTRMLTNAMEVTGL 888
Cdd:cd00142    107 WLNRRENFSCSLAGYSVLGYIFGIGDRHPSNIMIEP-SGNIFHIDFGFIFSGRKLAEGV-ETVPFRLTPMLENAMGTAGV 184
                          250       260       270
                   ....*....|....*....|....*....|..
gi 1878422027  889 DGNYRITCHTVMEVLREHRDSVMAVLEAFVYD 920
Cdd:cd00142    185 NGPFQISMVKIMEILREHADLIVPILEHSLRD 216
PIKKc_ATM cd05171
Catalytic domain of Ataxia Telangiectasia Mutated; ATM is critical in the response to DNA ...
649-927 7.43e-81

Catalytic domain of Ataxia Telangiectasia Mutated; ATM is critical in the response to DNA double strand breaks (DSBs) caused by radiation. It is activated at the site of a DSB and phosphorylates key substrates that trigger pathways that regulate DNA repair and cell cycle checkpoints at the G1/S, S phase, and G2/M transition. Patients with the human genetic disorder Ataxia telangiectasia (A-T), caused by truncating mutations in ATM, show genome instability, increased cancer risk, immunodeficiency, compromised mobility, and neurodegeneration. A-T displays clinical heterogeneity, which is correlated to the degree of retained ATM activity. ATM contains a FAT (FRAP, ATM and TRRAP) domain, a catalytic domain, and a FATC domain at the C-terminus. It is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). The ATM catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270715 [Multi-domain]  Cd Length: 282  Bit Score: 268.25  E-value: 7.43e-81
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  649 IQSIAPSLQVITSKQRPRKLTIMGSNGHEFMFLLKGHEDLRQDeRVM-QLFGLVNTLLANDPASLRKNLSIQRYAVIPLS 727
Cdd:cd05171      1 ISRFEDTFTLAGGINLPKIITCIGSDGKKYKQLVKGGDDLRQD-AVMeQVFELVNQLLKRDKETRKRKLRIRTYKVVPLS 79
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  728 TNSGLIGWVPHCDTLHALIRDY--------REKKKILLNIEHRIMLRMAPDYDhltLMEKVEVFEHAVNNTagddlaK-- 797
Cdd:cd05171     80 PRSGVLEFVENTIPLGEYLVGAssksgahaRYRPKDWTASTCRKKMREKAKAS---AEERLKVFDEICKNF------Kpv 150
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  798 ---LLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAmTREKFPEKIPFR 874
Cdd:cd05171    151 frhFFLEKFPDPSDWFERRLAYTRSVATSSIVGYILGLGDRHLNNILIDQKTGELVHIDLGIAFEQG-KLLPIPETVPFR 229
                          250       260       270       280       290
                   ....*....|....*....|....*....|....*....|....*....|...
gi 1878422027  875 LTRMLTNAMEVTGLDGNYRITCHTVMEVLREHRDSVMAVLEAFVYDPLLNWRL 927
Cdd:cd05171    230 LTRDIVDGMGITGVEGVFRRCCEETLRVLRENKEALLTILEVLLYDPLYSWTV 282
PIKKc_DNA-PK cd05172
Catalytic domain of DNA-dependent protein kinase; DNA-PK is comprised of a regulatory subunit, ...
649-926 7.19e-71

Catalytic domain of DNA-dependent protein kinase; DNA-PK is comprised of a regulatory subunit, containing the Ku70/80 subunit, and a catalytic subunit, which contains a NUC194 domain of unknown function, a FAT (FRAP, ATM and TRRAP) domain, a catalytic domain, and a FATC domain at the C-terminus. It is part of a multi-component system involved in non-homologous end joining (NHEJ), a process of repairing double strand breaks (DSBs) by joining together two free DNA ends of little homology. DNA-PK functions as a molecular sensor for DNA damage that enhances the signal via phosphorylation of downstream targets. It may also act as a protein scaffold that aids the localization of DNA repair proteins to the site of DNA damage. DNA-PK also plays a role in the maintenance of telomeric stability and the prevention of chromosomal end fusion. DNA-PK is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). The DNA-PK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270716 [Multi-domain]  Cd Length: 235  Bit Score: 237.47  E-value: 7.19e-71
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  649 IQSIAPSLQVITSKQRPRKLTIMGSNGHEFMFLLKGHEDLRQDERVMQLFGLVNTLLANDPASLRKNLSIQRYAVIPLST 728
Cdd:cd05172      1 IVGFDPRVLVLSSKRRPKRITIRGSDEKEYKFLVKGGEDLRQDQRIQQLFDVMNNILASDPACRQRRLRIRTYQVIPMTS 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  729 NSGLIGWVPHCDTLHALIRDYrekkkillniehriMLRMApdydhltlmekvevfehavnntagddlaklLWLKSPSSEV 808
Cdd:cd05172     81 RLGLIEWVDNTTPLKEILEND--------------LLRRA------------------------------LLSLASSPEA 116
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  809 WFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGL 888
Cdd:cd05172    117 FLALRSNFARSLAAMSICGYILGIGDRHLSNFLVDLSTGRLIGIDFGHAFGSATQFLPIPELVPFRLTRQLLNLLQPLDA 196
                          250       260       270
                   ....*....|....*....|....*....|....*...
gi 1878422027  889 DGNYRITCHTVMEVLREHRDSVMAVLEAFVYDPLLNWR 926
Cdd:cd05172    197 RGLLRSDMVHVLRALRAGRDLLLATMDVFVKEPLLDWQ 234
FRB_dom pfam08771
FKBP12-rapamycin binding domain; The macrolide antibiotic rapamycin and the cytosol protein ...
511-607 7.66e-59

FKBP12-rapamycin binding domain; The macrolide antibiotic rapamycin and the cytosol protein FKBP12 can form a complex which specifically inhibits the TORC1 complex, leading to growth arrest. The FKBP12-rapamycin complex interferes with TORC1 function by binding to the FKBP12-rapamycin binding domain (FRB) of the TOR proteins. This entry represents the FRB domain.


Pssm-ID: 462596  Cd Length: 98  Bit Score: 197.42  E-value: 7.66e-59
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  511 ELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFAVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQDWCRKYMRSGNV 590
Cdd:pfam08771    1 ELIRVAILWHELWYEGLEEASRLYFGEKNIEGMLKILEPLHEMLEKGPETLREISFAQAFGRDLQEAREWLKRYRKTGDE 80
                           90
                   ....*....|....*..
gi 1878422027  591 KDLTQAWDLYYHVFRRI 607
Cdd:pfam08771   81 EDLNQAWDIYYSVFRRI 97
DNA_pol_A_exo1 pfam01612
3'-5' exonuclease; This domain is responsible for the 3'-5' exonuclease proofreading activity ...
1299-1466 1.17e-53

3'-5' exonuclease; This domain is responsible for the 3'-5' exonuclease proofreading activity of E. coli DNA polymerase I (polI) and other enzymes, it catalyzes the hydrolysis of unpaired or mismatched nucleotides. This domain consists of the amino-terminal half of the Klenow fragment in E. coli polI it is also found in the Werner syndrome helicase (WRN), focus forming activity 1 protein (FFA-1) and ribonuclease D (RNase D). Werner syndrome is a human genetic disorder causing premature aging; the WRN protein has helicase activity in the 3'-5' direction. The FFA-1 protein is required for formation of a replication foci and also has helicase activity; it is a homolog of the WRN protein. RNase D is a 3'-5' exonuclease involved in tRNA processing. Also found in this family is the autoantigen PM/Scl thought to be involved in polymyositis-scleroderma overlap syndrome.


Pssm-ID: 396266 [Multi-domain]  Cd Length: 173  Bit Score: 185.58  E-value: 1.17e-53
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1299 CQFISSLEDLAALNEKLNQTTEFAVDLEHHSYR--SFLGITCLMQISTREEDFIIDTLELRSE-MYVLNESFTNPSIVKV 1375
Cdd:pfam01612    1 YRIVTTEDELEDLIEELLNAPYVAVDTETTSLDtySYYLRGALIQIGTGEGAYIIDPLALGDDvLSALKRLLEDPNITKV 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1376 FHGADSDIEWLQKDFGLYVVNMFDTHQASRSLNLGRN-SLDHLLKVFCNVDSNKRFQLADWRIRPLPEEMIKYAQADTHY 1454
Cdd:pfam01612   81 GHNAKFDLEVLARDFGIKLRNLFDTMLAAYLLGYDRShSLADLAEKYLGVELDKEEQCSDWQARPLSEEQLRYAALDADY 160
                          170
                   ....*....|..
gi 1878422027 1455 LLYVYDRLRADL 1466
Cdd:pfam01612  161 LLRLYDKLRKEL 172
Rnd COG0349
Ribonuclease D [Translation, ribosomal structure and biogenesis];
1301-1591 1.99e-53

Ribonuclease D [Translation, ribosomal structure and biogenesis];


Pssm-ID: 440118 [Multi-domain]  Cd Length: 365  Bit Score: 192.01  E-value: 1.99e-53
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1301 FISSLEDLAALNEKLNQTTEFAVDLEHHSYRSFLGITCLMQISTREEDFIIDTLELrSEMYVLNESFTNPSIVKVFHGAD 1380
Cdd:COG0349      1 LITTDEELAALCARLAQAPAVAVDTEFMRERTYYPRLCLIQLADGEEVALIDPLAI-GDLSPLWELLADPAIVKVFHAAR 79
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1381 SDIEWLQKDFGLYVVNMFDTHQASRSLNLGRN-SLDHLLKVFCNVDSNKRFQLADWRIRPLPEEMIKYAQADTHYLLYVY 1459
Cdd:COG0349     80 EDLEILYHLFGILPKPLFDTQIAAALLGYGDSvGYAALVEELLGVELDKSEQRSDWLRRPLSEEQLEYAAADVRYLLPLY 159
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1460 DRLRADLfdAANGQPALIQlvwSKSKDLCLKKYiKPIFTEESYLELykKQKKSFNGQQLSAFRFMYAWRDKLAREEDEST 1539
Cdd:COG0349    160 EKLLEEL--EREGRLEWAE---EECARLLDPAT-YREDPEEAWLRL--KGAWKLNPRQLAVLRELAAWREREARKRDVPR 231
                          250       260       270       280       290
                   ....*....|....*....|....*....|....*....|....*....|..
gi 1878422027 1540 GYILPNHMMMKISEELPKEPQGIIACCNPTPPLVRQQINELHQLIKQAREIP 1591
Cdd:COG0349    232 NRVLKDEALLELARRQPKSLEELARLRGLSPGEIRRHGEELLAAVAEALALP 283
RNaseD_exo cd06142
DEDDy 3'-5' exonuclease domain of Ribonuclease D and similar proteins; Ribonuclease (RNase) D ...
1307-1466 1.36e-50

DEDDy 3'-5' exonuclease domain of Ribonuclease D and similar proteins; Ribonuclease (RNase) D is a bacterial enzyme involved in the maturation of small stable RNAs and the 3' maturation of tRNA. It contains a DEDDy-type DnaQ-like 3'-5' exonuclease domain possessing three conserved sequence motifs termed ExoI, ExoII and ExoIII, with a specific YX(3)D pattern at ExoIII. These motifs are clustered around the active site and contain four conserved acidic residues that serve as ligands for the two metal ions required for catalysis. In vivo, RNase D only becomes essential upon removal of other ribonucleases. Eukaryotic RNase D homologs include yeast Rrp6p, human PM/Scl-100, and the Drosophila melanogaster egalitarian protein.


Pssm-ID: 176654 [Multi-domain]  Cd Length: 178  Bit Score: 176.95  E-value: 1.36e-50
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1307 DLAALNEKLNQTTEFAVDLEHHSYRSFLGITCLMQISTREEDFIIDTLELrSEMYVLNESFTNPSIVKVFHGADSDIEWL 1386
Cdd:cd06142      1 ELEDLCERLASAGVIAVDTEFMRLNTYYPRLCLIQISTGGEVYLIDPLAI-GDLSPLKELLADPNIVKVFHAAREDLELL 79
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1387 QKDFGLYVVNMFDTHQASRSLNLG-RNSLDHLLKVFCNVDSNKRFQLADWRIRPLPEEMIKYAQADTHYLLYVYDRLRAD 1465
Cdd:cd06142     80 KRDFGILPQNLFDTQIAARLLGLGdSVGLAALVEELLGVELDKGEQRSDWSKRPLTDEQLEYAALDVRYLLPLYEKLKEE 159

                   .
gi 1878422027 1466 L 1466
Cdd:cd06142    160 L 160
RNaseD_like cd06129
DEDDy 3'-5' exonuclease domain of RNase D, WRN, and similar proteins; The RNase D-like group ...
1307-1464 2.42e-44

DEDDy 3'-5' exonuclease domain of RNase D, WRN, and similar proteins; The RNase D-like group is composed of RNase D, WRN, and similar proteins. They contain a DEDDy-type, DnaQ-like, 3'-5' exonuclease domain that contains three conserved sequence motifs termed ExoI, ExoII and ExoIII, with a specific YX(3)D pattern at ExoIII. These motifs are clustered around the active site and contain four conserved acidic residues that serve as ligands for the two metal ions required for catalysis. RNase D is involved in the 3'-end processing of tRNA precursors. RNase D-like proteins in eukaryotes include yeast Rrp6p, human PM/Scl-100 and Drosophila melanogaster egalitarian (Egl) protein. WRN is a unique DNA helicase possessing exonuclease activity. Mutation in the WRN gene is implicated in Werner syndrome, a disease associated with premature aging and increased predisposition to cancer. Yeast Rrp6p and the human Polymyositis/scleroderma autoantigen 100kDa (PM/Scl-100) are exosome-associated proteins involved in the degradation and processing of precursors to stable RNAs. Egl is a component of an mRNA-binding complex which is required for oocyte specification. The Egl subfamily does not possess a completely conserved YX(3)D pattern at the ExoIII motif.


Pssm-ID: 176650 [Multi-domain]  Cd Length: 161  Bit Score: 158.45  E-value: 2.42e-44
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1307 DLAALNEKLNQTT-EFAVDLEHHSYRSFLGITCLMQISTREE-DFIIDTLELRSEMYVLNESFTNPSIVKVFHGADSDIE 1384
Cdd:cd06129      1 ALSSLCEDLSMDGdVIAFDMEWPPGRRYYGEVALIQLCVSEEkCYLFDPLSLSVDWQGLKMLLENPSIVKALHGIEGDLW 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1385 WLQKDFGLYVVNMFDTHQASRSLNL-GRNSLDHLLKVFCNVDSNKRFQLADWRIRPLPEEMIKYAQADTHYLLYVYDRLR 1463
Cdd:cd06129     81 KLLRDFGEKLQRLFDTTIAANLKGLpERWSLASLVEHFLGKTLDKSISCADWSYRPLTEDQKLYAAADVYALLIIYTKLR 160

                   .
gi 1878422027 1464 A 1464
Cdd:cd06129    161 N 161
35EXOc smart00474
3'-5' exonuclease; 3\' -5' exonuclease proofreading domain present in DNA polymerase I, Werner ...
1300-1466 4.34e-40

3'-5' exonuclease; 3\' -5' exonuclease proofreading domain present in DNA polymerase I, Werner syndrome helicase, RNase D and other enzymes


Pssm-ID: 214681 [Multi-domain]  Cd Length: 172  Bit Score: 146.73  E-value: 4.34e-40
                            10        20        30        40        50        60        70        80
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  1300 QFISSLEDLAALNEKL-NQTTEFAVDLEHHSYRSFLGITCLMQIS-TREEDFIIDTLELRSEMYVLNESFTNPSIVKVFH 1377
Cdd:smart00474    2 IVVTDSETLEELLEKLrAAGGEVALDTETTGLDSYSGKLVLIQISvTGEGAFIIDPLALGDDLEILKDLLEDETITKVGH 81
                            90       100       110       120       130       140       150       160
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  1378 GADSDIEWLQKdFGLYVVNMFDTHQASRSL--NLGRNSLDHLLKVFCNVDSNKRFQLADWRIRPLPEEMIKYAQADTHYL 1455
Cdd:smart00474   82 NAKFDLHVLAR-FGIELENIFDTMLAAYLLlgGPSKHGLATLLLGYLGVELDKEEQKSDWGARPLSEEQLEYAAEDADAL 160
                           170
                    ....*....|.
gi 1878422027  1456 LYVYDRLRADL 1466
Cdd:smart00474  161 LRLYEKLEKEL 171
PMC2NT pfam08066
PMC2NT (NUC016) domain; This domain is found at the N-terminus of 3'-5' exonucleases with HRDC ...
1089-1178 8.80e-28

PMC2NT (NUC016) domain; This domain is found at the N-terminus of 3'-5' exonucleases with HRDC domains, and also in putative exosome components.


Pssm-ID: 462352  Cd Length: 89  Bit Score: 108.42  E-value: 8.80e-28
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1089 VGATKASAGLPqaGDEYDFYRSF-PGFQDFCAVQGDRILHCMSQLMQHHGCRSHLRDRNKLTGLEERFDMVVDANDAILE 1167
Cdd:pfam08066    1 VSTTRAANALP--AQDIDFYRSLdPEFAESLDEQSARLLSLINSLLQSAGSKSNIKAPGDLDDVEDRWDSVVDVNDSLLE 78
                           90
                   ....*....|.
gi 1878422027 1168 KVGILLDEASG 1178
Cdd:pfam08066   79 KADICLDELTG 89
rnd TIGR01388
ribonuclease D; This model describes ribonuclease D, a 3'-exonuclease shown to act on tRNA ...
1302-1591 1.05e-26

ribonuclease D; This model describes ribonuclease D, a 3'-exonuclease shown to act on tRNA both in vitro and when overexpressed in vivo. Trusted members of this family are restricted to the Proteobacteria; Aquifex, Mycobacterial, and eukaryotic homologs are not full-length homologs. Ribonuclease D is not essential in E. coli and is deleterious when overexpressed. Its precise biological role is still unknown. [Transcription, RNA processing]


Pssm-ID: 130455 [Multi-domain]  Cd Length: 367  Bit Score: 114.10  E-value: 1.05e-26
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1302 ISSLEDLAALNEKLNQTTEFAVDLEHHSYRSFLGITCLMQISTREEDFIIDTLELrSEMYVLNESFTNPSIVKVFHGADS 1381
Cdd:TIGR01388    2 ITTDDELATVCEAVRTFPFVALDTEFVRERTFWPQLGLIQVADGEQLALIDPLVI-IDWSPLKELLRDESVVKVLHAASE 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1382 DIEWLQKDFGLYVVNMFDTHQASRSLNLGRN-SLDHLLKVFCNVDSNKRFQLADWRIRPLPEEMIKYAQADTHYLLYVYD 1460
Cdd:TIGR01388   81 DLEVFLNLFGELPQPLFDTQIAAAFCGFGMSmGYAKLVQEVLGVELDKSESRTDWLARPLTDAQLEYAAADVTYLLPLYA 160
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1461 RLRADLfDAANGQPALIQlvwskSKDLCLKKYIKPIFTEESYLELYKKQKksFNGQQLSAFRFMYAWRDKLAREEDESTG 1540
Cdd:TIGR01388  161 KLMERL-EESGRLAWLEE-----ECTLLTDRRTYVVNPEDAWRDIKNAWQ--LRPQQLAVLQALAAWREREARERDLPRN 232
                          250       260       270       280       290
                   ....*....|....*....|....*....|....*....|....*....|.
gi 1878422027 1541 YILPNHMMMKISEELPKEPqGIIACCNPTPPLVRQQINELHQLIKQAREIP 1591
Cdd:TIGR01388  233 FVLKEEALWELARQAPGNL-TELASLGPKGSEIRKHGDTLLALVKTALALP 282
PI3Kc_III cd00896
Catalytic domain of Class III Phosphoinositide 3-kinase; PI3Ks catalyze the transfer of the ...
641-906 7.72e-25

Catalytic domain of Class III Phosphoinositide 3-kinase; PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. Class III PI3Ks, also called Vps34 (vacuolar protein sorting 34), contain an N-terminal lipid binding C2 domain, a PI3K homology domain of unknown function, and a C-terminal ATP-binding cataytic domain. They phosphorylate only the substrate PtdIns. They interact with a regulatory subunit, Vps15, to form a membrane-associated complex. Class III PI3Ks are involved in protein and vesicular trafficking and sorting, autophagy, trimeric G-protein signaling, and phagocytosis. PI3Ks play an important role in a variety of fundamental cellular processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, immune cell activation and apoptosis. They can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270628 [Multi-domain]  Cd Length: 346  Bit Score: 108.00  E-value: 7.72e-25
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  641 DPNqpiIRIQSIAPS-LQVITSKQRPRKLTIMGSNGHEFMFLLKGHEDLRQDERVMQLFGLVNTLLANDpaSLrkNLSIQ 719
Cdd:cd00896     58 DPS---VKVTGIIPEkSTVFKSALMPLKLTFKTLDGGEYKVIFKHGDDLRQDQLVLQIITLMDRLLKKE--NL--DLKLT 130
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  720 RYAVIPLSTNSGLIGWVPHCDTLHALIRDYrekKKILlniehrimlrmapDYdhltlmekvevfehaVNNTAGDDLAKLL 799
Cdd:cd00896    131 PYKVLATSPNDGLVEFVPNSKALADILKKY---GSIL-------------NF---------------LRKHNPDESGPYG 179
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  800 wlkspsseVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRlSGKILHIDFG-----DCfevamtreK-FPEkiPF 873
Cdd:cd00896    180 --------IKPEVMDNFVKSCAGYCVITYILGVGDRHLDNLLLTK-DGHLFHIDFGyilgrDP--------KpFPP--PM 240
                          250       260       270
                   ....*....|....*....|....*....|....*
gi 1878422027  874 RLTRMLTNAMEVTGLDG--NYRITCHTVMEVLREH 906
Cdd:cd00896    241 KLCKEMVEAMGGANSEGykEFKKYCCTAYNILRKH 275
PIKK_TRRAP cd05163
Pseudokinase domain of TRansformation/tRanscription domain-Associated Protein; TRRAP belongs ...
649-890 5.53e-23

Pseudokinase domain of TRansformation/tRanscription domain-Associated Protein; TRRAP belongs to the the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. It contains a FATC (FRAP, ATM and TRRAP, C-terminal) domain and has a large molecular weight. Unlike most PIKK proteins, however, it contains an inactive PI3K-like pseudokinase domain, which lacks the conserved residues necessary for ATP binding and catalytic activity. TRRAP also contains many motifs that may be critical for protein-protein interactions. TRRAP is a common component of many histone acetyltransferase (HAT) complexes, and is responsible for the recruitment of these complexes to chromatin during transcription, replication, and DNA repair. TRRAP also exists in non-HAT complexes such as the p400 and MRN complexes, which are implicated in ATP-dependent remodeling and DNA repair, respectively. The TRRAP pseudokinase domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270707  Cd Length: 252  Bit Score: 100.29  E-value: 5.53e-23
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  649 IQSIAPSLQVITSKQRP-RKLTIMGSNGHEFMFLLK--GHEDLRQDERVMQLFGLVNTLLANDPASLRKNLSIQRYAVIP 725
Cdd:cd05163      1 IARFLPRVEIVRRHGTCyRRLTIRGHDGSKYPFLVQtpSARHSRREERVMQLFRLLNRVLERKKETRRRNLQFHVPIVVP 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  726 LSTNsgligwvphcdtlhalirdyrekkkillniehrimLR-MAPDYDHLTLM---EKVEVFEHAVNNTAGDDLAKLLWL 801
Cdd:cd05163     81 LSPQ-----------------------------------VRlVEDDPSYISLQdiyEKLEILNEIQSKMVPETILSNYFL 125
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  802 KS-PS-SEVWFDRRTnYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFgdCFEVAMTR--EKFPEKIPFRLTR 877
Cdd:cd05163    126 RTmPSpSDLWLFRKQ-FTLQLALSSFMTYVLSLGNRTPHRILISRSTGNVFMTDF--LPSINSQGplLDNNEPVPFRLTP 202
                          250
                   ....*....|...
gi 1878422027  878 MLTNAMEVTGLDG 890
Cdd:cd05163    203 NIQHFIGPIGVEG 215
PI3Kc cd00891
Catalytic domain of Phosphoinositide 3-kinase; PI3Ks catalyze the transfer of the ...
606-906 5.69e-21

Catalytic domain of Phosphoinositide 3-kinase; PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Ks play an important role in a variety of fundamental cellular processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, immune cell activation and apoptosis. They can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class I PI3Ks are the only enzymes capable of converting PtdIns(4,5)P2 to the critical second messenger PtdIns(3,4,5)P3. Class I enzymes are heterodimers and exist in multiple isoforms consisting of one catalytic subunit (out of four isoforms) and one of several regulatory subunits. Class II PI3Ks comprise three catalytic isoforms that do not associate with any regulatory subunits. They selectively use PtdIns as a susbtrate to produce PtsIns(3)P. The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270624 [Multi-domain]  Cd Length: 334  Bit Score: 96.49  E-value: 5.69e-21
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  606 RIAKQLPQLTSLELQYVSPKLLmcrdLELAVPGTYD-PNQPIIRIQSIAPS-LQVITSKQRPRKLTIMGS--NGHEFMFL 681
Cdd:cd00891     16 EIAKKIKEEPSEERKEVLEKLL----QKLELPKKFTlPLDPRMEVKGLIVEkCKVMDSKKLPLWLVFKNAdpGGDPIKVI 91
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  682 LKGHEDLRQDERVMQLFGLVNTLLANdpASLrkNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILlnieh 761
Cdd:cd00891     92 FKAGDDLRQDQLTLQLLRIMDKLWKK--EGL--DLRMTPYKCIATGDEVGMIEVVPNSETTAAIQKKYGGFGAAF----- 162
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  762 rimlrmapdydhltlmeKVEVFEHavnntagddlakllWLKS--PSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSN 839
Cdd:cd00891    163 -----------------KDTPISN--------------WLKKhnPTEEEYEEAVENFIRSCAGYCVATYVLGIGDRHNDN 211
                          250       260       270       280       290       300       310
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1878422027  840 LMLDRlSGKILHIDFG---DCFevamtREKF---PEKIPFRLTRMLTNAMevTGLDGN----YRITCHTVMEVLREH 906
Cdd:cd00891    212 IMVTK-SGHLFHIDFGhflGNF-----KKKFgikRERAPFVFTPEMAYVM--GGEDSEnfqkFEDLCCKAYNILRKH 280
HRDC smart00341
Helicase and RNase D C-terminal; Hypothetical role in nucleic acid binding. Mutations in the ...
1516-1594 3.52e-16

Helicase and RNase D C-terminal; Hypothetical role in nucleic acid binding. Mutations in the HRDC domain cause human disease.


Pssm-ID: 128635 [Multi-domain]  Cd Length: 81  Bit Score: 75.03  E-value: 3.52e-16
                            10        20        30        40        50        60        70
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1878422027  1516 QQLSAFRFMYAWRDKLAREEDESTGYILPNHMMMKISEELPKEPQGIIACCNPTPPLVRQQINELHQLIKQAREIPLLK 1594
Cdd:smart00341    3 RQLRLLRRLRQWRDEIARREDVPPYFVLPDETLIKMAAALPTNVSELLAIDGVGEEKARRYGKDLLAVIQEASDSPSEA 81
PI3Kc_I cd05165
Catalytic domain of Class I Phosphoinositide 3-kinase; PI3Ks catalyze the transfer of the ...
658-876 3.69e-14

Catalytic domain of Class I Phosphoinositide 3-kinase; PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. Class I PI3Ks are the only enzymes capable of converting PtdIns(4,5)P2 to the critical second messenger PtdIns(3,4,5)P3. In vitro, they can also phosphorylate the substrates PtdIns and PtdIns(4)P. Class I enzymes are heterodimers and exist in multiple isoforms consisting of one catalytic subunit (out of four isoforms) and one of several regulatory subunits. They are further classified into class IA (alpha, beta and delta) and IB (gamma). PI3Ks play an important role in a variety of fundamental cellular processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, immune cell activation and apoptosis. They can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270709 [Multi-domain]  Cd Length: 363  Bit Score: 76.13  E-value: 3.69e-14
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  658 VITSKQRPRKLT-----IMGSNGHEFMFLLKGHEDLRQDERVMQLFGLVNTLLANDPASLRKNLsiqrYAVIPLSTNSGL 732
Cdd:cd05165     71 VMDSKKRPLWLVfenadPLALSGEDIKIIFKNGDDLRQDMLTLQIIRIMDNIWKEEGLDLRMLP----YGCLSTGDNVGL 146
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  733 IGWVPHCDTLhalirdyrekkkilLNI--EHRIMLRMApdydhltlMEKVEVFEhavnntagddlakllWLK--SPSSEV 808
Cdd:cd05165    147 IEVVRNAKTI--------------ANIqkKKGKVATLA--------FNKDSLHK---------------WLKekNKTGEK 189
                          170       180       190       200       210       220       230
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1878422027  809 wFDRR-TNYTRSLAVMSMVGYILGLGDRHPSNLMLDRlSGKILHIDFG---DCFevamtREKF---PEKIPFRLT 876
Cdd:cd05165    190 -YDRAiEEFTLSCAGYCVATYVLGIGDRHSDNIMVKE-NGQLFHIDFGhflGNF-----KKKFgikRERVPFVLT 257
HRDC pfam00570
HRDC domain; The HRDC (Helicase and RNase D C-terminal) domain has a putative role in nucleic ...
1517-1584 5.27e-14

HRDC domain; The HRDC (Helicase and RNase D C-terminal) domain has a putative role in nucleic acid binding. Mutations in the HRDC domain cause human disease. It is interesting to note that the RecQ helicase in Deinococcus radiodurans has three tandem HRDC domains.


Pssm-ID: 425755 [Multi-domain]  Cd Length: 68  Bit Score: 68.33  E-value: 5.27e-14
                           10        20        30        40        50        60
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1878422027 1517 QLSAFRFMYAWRDKLAREEDESTGYILPNHMMMKISEELPKEPQGIIACCNPTPPLVRQQINELHQLI 1584
Cdd:pfam00570    1 QLALLKALREWRDELAREEDVPPYVIFPDKTLLEIAEKLPRTLEELLAIPGVGPRKVERYGEEILAAI 68
PI3Kc_II cd05166
Catalytic domain of Class II Phosphoinositide 3-kinase; PI3Ks catalyze the transfer of the ...
658-876 5.45e-14

Catalytic domain of Class II Phosphoinositide 3-kinase; PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Ks play an important role in a variety of fundamental cellular processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, immune cell activation and apoptosis. They can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class II PI3Ks preferentially use PtdIns as a substrate to produce PtdIns(3)P, but can also phosphorylate PtdIns(4)P. They function as monomers and do not associate with any regulatory subunits. Class II enzymes contain an N-terminal Ras binding domain, a lipid binding C2 domain, a PI3K homology domain of unknown function, an ATP-binding cataytic domain, a Phox homology (PX) domain, and a second C2 domain at the C-terminus. They are activated by a variety of stimuli including chemokines, cytokines, lysophosphatidic acid (LPA), insulin, and tyrosine kinase receptors. The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270710 [Multi-domain]  Cd Length: 352  Bit Score: 75.79  E-value: 5.45e-14
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  658 VITSKQRPRKLTIMGSN--GHEFMFLLKGHEDLRQDERVMQLFGLVNTL-LANdpaslRKNLSIQRYAVIPLSTNSGLIG 734
Cdd:cd05166     69 YFNSNALPLKLVFRNADprAEPISVIFKVGDDLRQDMLTLQLIRIMDKIwLQE-----GLDLKMITFRCVPTGNKRGMVE 143
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  735 WVPHCDTLhalirdyREKKKillniehrimlrmapdydhltlmekvevfEHAVNNTAGDD-LAKLLWLKSPSSEVWFDRR 813
Cdd:cd05166    144 LVPEAETL-------REIQT-----------------------------EHGLTGSFKDRpLADWLQKHNPSELEYEKAV 187
                          170       180       190       200       210       220
                   ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1878422027  814 TNYTRSLAVMSMVGYILGLGDRHPSNLMLDRlSGKILHIDFGDCFEVAMTREKFP-EKIPFRLT 876
Cdd:cd05166    188 ENFIRSCAGYCVATYVLGICDRHNDNIMLKT-SGHLFHIDFGKFLGDAQMFGNFKrDRVPFVLT 250
PI4Kc_III cd00893
Catalytic domain of Type III Phosphoinositide 4-kinase; PI4Ks catalyze the transfer of the ...
680-917 1.16e-13

Catalytic domain of Type III Phosphoinositide 4-kinase; PI4Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 4-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) to generate PtdIns(4)P, the major precursor in the synthesis of other phosphoinositides including PtdIns(4,5)P2, PtdIns(3,4)P2, and PtdIns(3,4,5)P3. There are two types of PI4Ks, types II and III. Type II PI4Ks lack the characteristic catalytic kinase domain present in PI3Ks and type III PI4Ks, and are excluded from this family. Two isoforms of type III PI4K, alpha and beta, exist in most eukaryotes. The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270626 [Multi-domain]  Cd Length: 286  Bit Score: 73.45  E-value: 1.16e-13
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  680 FLLKGHEDLRQDERVMQLFGLVNTLLANDpaslRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILlni 759
Cdd:cd00893     30 LIVKTGDDLKQEQLALQLISQFDQIFKEE----GLPLWLRPYEILSLGPDSGIIEMIKNAVSIDSLKKKLDSFNKFV--- 102
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  760 ehrimlrmapdydhlTLMEkveVFEHAVNNTAGDDLakllwlkspssevwfdrRTNYTRSLAVMSMVGYILGLGDRHPSN 839
Cdd:cd00893    103 ---------------SLSD---FFDDNFGDEAIQKA-----------------RDNFLQSLVAYSLVCYFLQIKDRHNGN 147
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  840 LMLDRlSGKILHIDFGDCFEVAMTREKFpEKIPFRLTRMLTNAMEvtGLDGN----YRITCHTVMEVLREHRDSVMAVLE 915
Cdd:cd00893    148 ILLDK-EGHIIHIDFGFFLSSHPGFYGF-EGAPFKLSSEYIEVLG--GVDSElfkeFRKLFLKGFMALRKHSDKILSLVE 223

                   ..
gi 1878422027  916 AF 917
Cdd:cd00893    224 MM 225
PI4Kc_III_beta cd05168
Catalytic domain of Type III Phosphoinositide 4-kinase beta; PI4Ks catalyze the transfer of ...
680-915 2.57e-13

Catalytic domain of Type III Phosphoinositide 4-kinase beta; PI4Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 4-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) to generate PtdIns(4)P, the major precursor in the synthesis of other phosphoinositides including PtdIns(4,5)P2, PtdIns(3,4)P2, and PtdIns(3,4,5)P3. Two isoforms of type III PI4K, alpha and beta, exist in most eukaryotes. PI4KIIIbeta (also called Pik1p in yeast) is a 110 kDa protein that is localized to the Golgi and the nucleus. It is required for maintaining the structural integrity of the Golgi complex (GC), and is a key regulator of protein transport from the GC to the plasma membrane. PI4KIIIbeta also functions in the genesis, transport, and exocytosis of synaptic vesicles. The Drosophila PI4KIIIbeta is essential for cytokinesis during spermatogenesis. The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270712 [Multi-domain]  Cd Length: 292  Bit Score: 72.51  E-value: 2.57e-13
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  680 FLLKGHEDLRQDERVMQLFGLVNTLLANdpASLrkNLSIQRYAVIPLSTNSGLIGWVPhcDT--LHALirdyreKKKill 757
Cdd:cd05168     33 VIVKSGDDLRQELLAMQLIKQFQRIFEE--AGL--PLWLRPYEILVTSSDSGLIETIP--DTvsIDSL------KKR--- 97
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  758 niehrimlrmAPDYDHLTlmekvEVFEhavnNTAGDdlakllwlksPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHP 837
Cdd:cd05168     98 ----------FPNFTSLL-----DYFE----RTFGD----------PNSERFKEAQRNFVESLAAYSLVCYLLQIKDRHN 148
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  838 SNLMLDRlSGKILHIDFGDCFEVAMTREKFpEKIPFRLTRMLTNAMEvtGLDGN----YRITCHTVMEVLREHRDSVMAV 913
Cdd:cd05168    149 GNILLDS-EGHIIHIDFGFMLSNSPGGLGF-ETAPFKLTQEYVEVMG--GLESDmfryFKTLMIQGFLALRKHADRIVLL 224

                   ..
gi 1878422027  914 LE 915
Cdd:cd05168    225 VE 226
PI3Kc_IA_delta cd05174
Catalytic domain of Class IA Phosphoinositide 3-kinase delta; PI3Ks catalyze the transfer of ...
643-906 3.36e-13

Catalytic domain of Class IA Phosphoinositide 3-kinase delta; PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Kdelta is mainly expressed in immune cells and plays an important role in cellular and humoral immunity. It plays a major role in antigen receptor signaling in B-cells, T-cells, and mast cells. It regulates the differentiation of peripheral helper T-cells and controls the development and function of regulatory T-cells. PI3Ks can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class I PI3Ks are the only enzymes capable of converting PtdIns(4,5)P2 to the critical second messenger PtdIns(3,4,5)P3. Class I enzymes are heterodimers and exist in multiple isoforms consisting of one catalytic subunit (out of four isoforms) and one of several regulatory subunits. They are further classified into class IA (alpha, beta and delta) and IB (gamma). Class IA enzymes contain an N-terminal p85 binding domain, a Ras binding domain, a lipid binding C2 domain, a PI3K homology domain of unknown function, and a C-terminal ATP-binding cataytic domain. They associate with a regulatory subunit of the p85 family and are activated by tyrosine kinase receptors. The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270718 [Multi-domain]  Cd Length: 366  Bit Score: 73.55  E-value: 3.36e-13
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  643 NQPIIRIQSIAPSLQVITSKQRPrkLTIMGSN----GHEFMFLLKGHEDLRQDERVMQLFGLVNTLLANDPASLRknlsI 718
Cdd:cd05174     61 DPSIILEEVCVDQCTFMDSKMKP--LWIMYSSeeagAGNVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLR----M 134
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  719 QRYAVIPLSTNSGLIGWVPHCDTLhalirdyrekKKILLNIEHrimlrMAPdydhltlmekvevfehavnNTAGDDLAKL 798
Cdd:cd05174    135 TPYGCLSTGDKTGLIEVVLHSDTI----------ANIQLNKSN-----MAA-------------------TAAFNKDALL 180
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  799 LWLKSPSSEVWFDRRTN-YTRSLAVMSMVGYILGLGDRHPSNLMLdRLSGKILHIDFGDCfeVAMTREKF---PEKIPFR 874
Cdd:cd05174    181 NWLKSKNPGDALDQAIEeFTLSCAGYCVATYVLGIGDRHSDNIMI-RESGQLFHIDFGHF--LGNFKTKFginRERVPFI 257
                          250       260       270
                   ....*....|....*....|....*....|....*...
gi 1878422027  875 LTRMLTNAMEvTGLDGN------YRITCHTVMEVLREH 906
Cdd:cd05174    258 LTYDFVHVIQ-QGKTNNsekferFRGYCERAYTILRRH 294
Egl_like_exo cd06148
DEDDy 3'-5' exonuclease domain of Drosophila Egalitarian (Egl) and similar proteins; The ...
1335-1467 8.13e-13

DEDDy 3'-5' exonuclease domain of Drosophila Egalitarian (Egl) and similar proteins; The Egalitarian (Egl) protein subfamily is composed of Drosophila Egl and similar proteins. Egl is a component of an mRNA-binding complex which is required for oocyte specification. Egl contains a DEDDy-type DnaQ-like 3'-5' exonuclease domain possessing three conserved sequence motifs termed ExoI, ExoII and ExoIII, with a specific YX(3)D pattern at ExoIII. The motifs are clustered around the active site and contain four conserved acidic residues that serve as ligands for the two metal ions required for catalysis. The conservation of this subfamily throughout eukaryotes suggests that its members may be part of ancient RNA processing complexes that are likely to participate in the regulated processing of specific mRNAs. Some members of this subfamily do not have a completely conserved YX(3)D pattern at the ExoIII motif.


Pssm-ID: 99851  Cd Length: 197  Bit Score: 69.24  E-value: 8.13e-13
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1335 GITCLMQISTREED-FIIDTLELRSE--MYVLNESFTNPSIVKVFHGADSDIEWLQKDFGLYVVNMFDT--------HQA 1403
Cdd:cd06148     26 GKLCLVQIATRTGQiYLFDILKLGSIvfINGLKDILESKKILKVIHDCRRDSDALYHQYGIKLNNVFDTqvadallqEQE 105
                           90       100       110       120       130       140       150
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1878422027 1404 SRSLNLGR-NSLDHLLKVFCNVDSNKRFQLAD--------WRIRPLPEEMIKYAQADTHYLLYVYDRLRADLF 1467
Cdd:cd06148    106 TGGFNPDRvISLVQLLDKYLYISISLKEDVKKlmredpkfWALRPLTEDMIRYAALDVLCLLPLYYAMLDALI 178
PRK10829 PRK10829
ribonuclease D; Provisional
1298-1536 9.57e-13

ribonuclease D; Provisional


Pssm-ID: 236771 [Multi-domain]  Cd Length: 373  Bit Score: 71.96  E-value: 9.57e-13
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1298 NCQFISSLEDLAALNEKLNQTTEFAVDLEHHSYRSF---LGitcLMQISTREEDFIIDTLELrSEMYVLNESFTNPSIVK 1374
Cdd:PRK10829     2 NYQMITTDDALASVCEAARAFPAIALDTEFVRTRTYypqLG---LIQLYDGEQLSLIDPLGI-TDWSPFKALLRDPQVTK 77
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1375 VFHGADSDIEWLQKDFGLYVVNMFDTHQAS----RSLNLGRNSLdhlLKVFCNVDSNKRFQLADWRIRPLPEEMIKYAQA 1450
Cdd:PRK10829    78 FLHAGSEDLEVFLNAFGELPQPLIDTQILAafcgRPLSCGFASM---VEEYTGVTLDKSESRTDWLARPLSERQCEYAAA 154
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1451 DTHYLLYVYDRLRADLfdAANGQpaliqlvWSKSKDLCL------KKYIKPiftEESYLELYKKQKksFNGQQLSAFRFM 1524
Cdd:PRK10829   155 DVFYLLPIAAKLMAET--EAAGW-------LPAALDECRllcqrrQEVLAP---EEAYRDITNAWQ--LRTRQLACLQLL 220
                          250
                   ....*....|..
gi 1878422027 1525 YAWRDKLAREED 1536
Cdd:PRK10829   221 ADWRLRKARERD 232
PI4Kc_III_alpha cd05167
Catalytic domain of Type III Phosphoinositide 4-kinase alpha; PI4Ks catalyze the transfer of ...
683-883 2.00e-12

Catalytic domain of Type III Phosphoinositide 4-kinase alpha; PI4Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 4-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) to generate PtdIns(4)P, the major precursor in the synthesis of other phosphoinositides including PtdIns(4,5)P2, PtdIns(3,4)P2, and PtdIns(3,4,5)P3. Two isoforms of type III PI4K, alpha and beta, exist in most eukaryotes. PI4KIIIalpha is a 220 kDa protein found in the plasma membrane and the endoplasmic reticulum (ER). The role of PI4KIIIalpha in the ER remains unclear. In the plasma membrane, it provides PtdIns(4)P, which is then converted by PI5Ks to PtdIns(4,5)P2, an important signaling molecule. Vertebrate PI4KIIIalpha is also part of a signaling complex associated with P2X7 ion channels. The yeast homolog, Stt4p, is also important in regulating the conversion of phosphatidylserine to phosphatidylethanolamine at the ER and Golgi interface. Mammalian PI4KIIIalpha is highly expressed in the nervous system. The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270711 [Multi-domain]  Cd Length: 307  Bit Score: 70.32  E-value: 2.00e-12
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  683 KGHEDLRQDERVMQLFGLVNTLLANdpaslrKNLSI--QRYAVIPLSTNSGLIGWVPHCDTLHALIRDYRekkkillnie 760
Cdd:cd05167     55 KVGDDCRQDMLALQLISLFKNIFEE------VGLDLylFPYRVVATGPGCGVIEVIPNSKSRDQIGRETD---------- 118
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  761 hrimlrmapdydhltlMEKVEVFEHavnnTAGDdlakllwlksPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNL 840
Cdd:cd05167    119 ----------------NGLYEYFLS----KYGD----------ESTPAFQKARRNFIKSMAGYSLVSYLLQIKDRHNGNI 168
                          170       180       190       200
                   ....*....|....*....|....*....|....*....|....*..
gi 1878422027  841 MLDRlSGKILHIDFGDCFEVA----MtreKFpEKIPFRLTRMLTNAM 883
Cdd:cd05167    169 MIDD-DGHIIHIDFGFIFEISpggnL---GF-ESAPFKLTKEMVDLM 210
mut-7_like_exo cd06146
DEDDy 3'-5' exonuclease domain of Caenorhabditis elegans mut-7 and similar proteins; The mut-7 ...
1338-1463 5.19e-12

DEDDy 3'-5' exonuclease domain of Caenorhabditis elegans mut-7 and similar proteins; The mut-7 subfamily is composed of Caenorhabditis elegans mut-7 and similar proteins found in plants and metazoans. Mut-7 is implicated in posttranscriptional gene silencing. It contains a DEDDy-type DnaQ-like 3'-5' exonuclease domain possessing three conserved sequence motifs, termed ExoI, ExoII and ExoIII, with a specific YX(3)D pattern at ExoIII. These motifs are clustered around the active site and contain four conserved acidic residues that serve as ligands for the two metal ions required for catalysis.


Pssm-ID: 176655  Cd Length: 193  Bit Score: 66.55  E-value: 5.19e-12
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1338 CLMQISTREEDFIIDTLEL---RSEMY--VLNESFTNPSIVKVFHGADSDIEWLQKDFGLY---------VVNMFDTHQA 1403
Cdd:cd06146     44 AILQLATEDEVFLLDLLALenlESEDWdrLLKRLFEDPDVLKLGFGFKQDLKALSASYPALkcmfervqnVLDLQNLAKE 123
                           90       100       110       120       130       140       150
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1404 SRSLNLGRnSLDHLLKVFCNVDS----------NKRFQLADWRIRPLPEEMIKYAQADTHYLLYVYDRLR 1463
Cdd:cd06146    124 LQKSDMGR-LKGNLPSKTKGLADlvqevlgkplDKSEQCSNWERRPLREEQILYAALDAYCLLEVFDKLL 192
WRN_exo cd06141
DEDDy 3'-5' exonuclease domain of WRN and similar proteins; WRN is a unique RecQ DNA helicase ...
1337-1464 3.03e-10

DEDDy 3'-5' exonuclease domain of WRN and similar proteins; WRN is a unique RecQ DNA helicase exhibiting an exonuclease activity. It contains a DEDDy-type DnaQ-like 3'-5' exonuclease domain possessing three conserved sequence motifs termed ExoI, ExoII and ExoIII, with a specific YX(3)D pattern at ExoIII. These motifs are clustered around the active site and contain four conserved acidic residues that serve as ligands for the two metal ions required for catalysis. Mutations in the WRN gene cause Werner syndrome, an autosomal recessive disorder associated with premature aging and increased susceptibility to cancer and type II diabetes. WRN interacts with key proteins involved in DNA replication, recombination, and repair. It is believed to maintain genomic stability and life span by participating in DNA processes. WRN is stimulated by Ku70/80, an important regulator of genomic stability.


Pssm-ID: 176653 [Multi-domain]  Cd Length: 170  Bit Score: 61.06  E-value: 3.03e-10
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1337 TCLMQISTREEDFIIDTLELRSEMYVLNESFTNPSIVKVFHGADSDIEWLQKDFGLYVVNMFDTHQASRSLNLGRN--SL 1414
Cdd:cd06141     39 VALLQLATESRCLLFQLAHMDKLPPSLKQLLEDPSILKVGVGIKGDARKLARDFGIEVRGVVDLSHLAKRVGPRRKlvSL 118
                           90       100       110       120       130
                   ....*....|....*....|....*....|....*....|....*....|..
gi 1878422027 1415 DHLLKVFCNV--DSNKRFQLADWRIRPLPEEMIKYAQADTHYLLYVYDRLRA 1464
Cdd:cd06141    119 ARLVEEVLGLplSKPKKVRCSNWEARPLSKEQILYAATDAYASLELYRKLLA 170
PI3Kc_C2_alpha cd05176
Catalytic domain of Class II Phosphoinositide 3-kinase alpha; PI3Ks catalyze the transfer of ...
660-876 1.13e-09

Catalytic domain of Class II Phosphoinositide 3-kinase alpha; PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. The class II alpha isoform, PI3K-C2alpha, plays key roles in clathrin assembly and clathrin-mediated membrane trafficking, insulin signaling, vascular smooth muscle contraction, and the priming of neurosecretory granule exocytosis. PI3Ks play an important role in a variety of fundamental cellular processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, immune cell activation and apoptosis. They can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class II PI3Ks preferentially use PtdIns as a substrate to produce PtdIns(3)P, but can also phosphorylate PtdIns(4)P. They function as monomers and do not associate with any regulatory subunits. Class II enzymes contain an N-terminal Ras binding domain, a lipid binding C2 domain, a PI3K homology domain of unknown function, an ATP-binding cataytic domain, a Phox homology (PX) domain, and a second C2 domain at the C-terminus. The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270720 [Multi-domain]  Cd Length: 353  Bit Score: 62.30  E-value: 1.13e-09
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  660 TSKQRPRKLTIMGSN--GHEFMFLLKGHEDLRQDERVMQLFGLVNTLLANDPASLRKNLsiqrYAVIPLSTNSGLIGWVP 737
Cdd:cd05176     71 SSNAVPLKVALVNADplGEEINVMFKVGEDLRQDMLALQMIKIMDKIWLQEGLDLRMVI----FKCLSTGKDRGMVELVP 146
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  738 HCDTLhalirdyrekkkillniehrimlrmapdydhltlmEKVEVfEHAVNNTAGDD-LAKLLWLKSPSSEVWFDRRTNY 816
Cdd:cd05176    147 SSDTL-----------------------------------RKIQV-EYGVTGSFKDKpLAEWLRKYNPSEEEYEKASENF 190
                          170       180       190       200       210       220
                   ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1878422027  817 TRSLAVMSMVGYILGLGDRHPSNLMLdRLSGKILHIDFGDCFEVAMTREKFP-EKIPFRLT 876
Cdd:cd05176    191 IYSCAGCCVATYVLGICDRHNDNIML-RSTGHMFHIDFGKFLGHAQMFGSFKrDRAPFVLT 250
PI3Kc_IA_beta cd05173
Catalytic domain of Class IA Phosphoinositide 3-kinase beta; PI3Ks catalyze the transfer of ...
661-906 5.06e-09

Catalytic domain of Class IA Phosphoinositide 3-kinase beta; PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Kbeta can be activated by G-protein-coupled receptors. Deletion of PI3Kbeta in mice results in early lethality at around day three of development. PI3Kbeta plays an important role in regulating sustained integrin activation and stable platelet agrregation, especially under conditions of high shear stress. PI3Ks can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class I PI3Ks are the only enzymes capable of converting PtdIns(4,5)P2 to the critical second messenger PtdIns(3,4,5)P3. Class I enzymes are heterodimers and exist in multiple isoforms consisting of one catalytic subunit (out of four isoforms) and one of several regulatory subunits. They are further classified into class IA (alpha, beta and delta) and IB (gamma). Class IA enzymes contain an N-terminal p85 binding domain, a Ras binding domain, a lipid binding C2 domain, a PI3K homology domain of unknown function, and a C-terminal ATP-binding cataytic domain. They associate with a regulatory subunit of the p85 family and are activated by tyrosine kinase receptors. The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270717 [Multi-domain]  Cd Length: 362  Bit Score: 60.36  E-value: 5.06e-09
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  661 SKQRPrkLTIMGSN----GHEFMFLLKGHEDLRQDERVMQLFGLVNTLLANDPASLRknlsIQRYAVIPLSTNSGLIGWV 736
Cdd:cd05173     76 SKMKP--LWIVYNNklfgGDSLGIIFKNGDDLRQDMLTLQILRLMDTLWKEAGLDLR----IVPYGCLATGDRSGLIEVV 149
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  737 PHCDTLhalirdyrekKKILLNiEHRIMLRMAPDYDHLtlmekvevfehavnntagddlakLLWLKSPSSEVWFDRRTN- 815
Cdd:cd05173    150 SSAETI----------ADIQLN-SSNVAAAAAFNKDAL-----------------------LNWLKEYNSGDDLERAIEe 195
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  816 YTRSLAVMSMVGYILGLGDRHPSNLMLdRLSGKILHIDFGDCfeVAMTREKFP---EKIPFRLTRMLTNAMEvTGLDGN- 891
Cdd:cd05173    196 FTLSCAGYCVATYVLGIGDRHSDNIMV-RKNGQLFHIDFGHI--LGNFKSKFGikrERVPFILTYDFIHVIQ-QGKTGNt 271
                          250       260
                   ....*....|....*....|
gi 1878422027  892 -----YRITCHTVMEVLREH 906
Cdd:cd05173    272 ekfgrFRQYCEDAYLILRKN 291
FATC pfam02260
FATC domain; The FATC domain is named after FRAP, ATM, TRRAP C-terminal. The solution ...
1014-1043 6.07e-09

FATC domain; The FATC domain is named after FRAP, ATM, TRRAP C-terminal. The solution structure of the FATC domain suggests it plays a role in redox-dependent structural and cellular stability.


Pssm-ID: 460514 [Multi-domain]  Cd Length: 32  Bit Score: 52.77  E-value: 6.07e-09
                           10        20        30
                   ....*....|....*....|....*....|
gi 1878422027 1014 TLDVPTQVELLIKQATSHENLCQCYIGCMA 1043
Cdd:pfam02260    1 PLSVEGQVDELIQEATDPENLAQMYIGWCP 30
DEDDy_polA_RNaseD_like_exo cd09018
DEDDy 3'-5' exonuclease domain of family-A DNA polymerases, RNase D, WRN, and similar proteins; ...
1321-1462 1.13e-07

DEDDy 3'-5' exonuclease domain of family-A DNA polymerases, RNase D, WRN, and similar proteins; DEDDy exonucleases, part of the DnaQ-like (or DEDD) exonuclease superfamily, catalyze the excision of nucleoside monophosphates at the DNA or RNA termini in the 3'-5' direction. They contain four invariant acidic residues in three conserved sequence motifs termed ExoI, ExoII and ExoIII. DEDDy exonucleases are classified as such because of the presence of a specific YX(3)D pattern at ExoIII. The four conserved acidic residues serve as ligands for the two metal ions required for catalysis. This family of DEDDy exonucleases includes the proofreading domains of family A DNA polymerases, as well as RNases such as RNase D and yeast Rrp6p. The Egalitarian (Egl) and Bacillus-like DNA Polymerase I subfamilies do not possess a completely conserved YX(3)D pattern at the ExoIII motif. In addition, the Bacillus-like DNA polymerase I subfamily has inactive 3'-5' exonuclease domains which do not possess the metal-binding residues necessary for activity.


Pssm-ID: 176656 [Multi-domain]  Cd Length: 150  Bit Score: 53.01  E-value: 1.13e-07
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1321 FAVDLEHHSYRSFLGITCLMQISTREED-FIIDTLELRSEMYVLNESFTNPSIVKVFHGADSDIEWLQKDFGLYVVNMFD 1399
Cdd:cd09018      2 FAFDTETDSLDNISANLVLIQLAIEPGVaALIPVAHDYLALELLKPLLEDEKALKVGQNLKYDRGILLNYFIELRGIAFD 81
                           90       100       110       120       130       140
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1878422027 1400 THQASRSLN--LGRNSLDHLLKVFCNVDSNKRFQLAD--WRIRPLPEEMIKYAQADTHYLLYVYDRL 1462
Cdd:cd09018     82 TMLEAYILNsvAGRWDMDSLVERWLGHKLIKFESIAGklWFNQPLTEEQGRYAAEDADVTLQIHLKL 148
PI3Kc_IA_alpha cd05175
Catalytic domain of Class IA Phosphoinositide 3-kinase alpha; PI3Ks catalyze the transfer of ...
611-877 1.68e-06

Catalytic domain of Class IA Phosphoinositide 3-kinase alpha; PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Kalpha plays an important role in insulin signaling. It also mediates physiologic heart growth and provides protection from stress. Activating mutations of PI3Kalpha is associated with diverse forms of cancer at high frequency. PI3Ks can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class I PI3Ks are the only enzymes capable of converting PtdIns(4,5)P2 to the critical second messenger PtdIns(3,4,5)P3. Class I enzymes are heterodimers and exist in multiple isoforms consisting of one catalytic subunit (out of four isoforms) and one of several regulatory subunits. They are further classified into class IA (alpha, beta and delta) and IB (gamma). Class IA enzymes contain an N-terminal p85 binding domain, a Ras binding domain, a lipid binding C2 domain, a PI3K homology domain of unknown function, and a C-terminal ATP-binding cataytic domain. They associate with a regulatory subunit of the p85 family and are activated by tyrosine kinase receptors. The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270719 [Multi-domain]  Cd Length: 370  Bit Score: 52.37  E-value: 1.68e-06
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  611 LPQLTSLELQYVSPKLLMCR----DLELAVPGTYDPNQPIIRIQSIA-PSLQVITSKQRPRKLTIMGSN-GHEFMF---- 680
Cdd:cd05175     25 LKQEKKDETQKVQMKFLVEQmrrpDFMDALQGFLSPLNPAHQLGNLRlEECRIMSSAKRPLWLNWENPDiMSELLFqnne 104
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  681 -LLKGHEDLRQDERVMQLFGLVNTLLANDPASLRknlsIQRYAVIPLSTNSGLIGWVPHCDTLhalirdyrekkkilLNI 759
Cdd:cd05175    105 iIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLR----MLPYGCLSIGDCVGLIEVVRNSHTI--------------MQI 166
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  760 EHRIMLRMAPDYDHLTLMEkvevfehavnntagddlakllWLKSPSSEVWFDRRTN-YTRSLAVMSMVGYILGLGDRHPS 838
Cdd:cd05175    167 QCKGGLKGALQFNSHTLHQ---------------------WLKDKNKGEIYDAAIDlFTRSCAGYCVATFILGIGDRHNS 225
                          250       260       270       280
                   ....*....|....*....|....*....|....*....|..
gi 1878422027  839 NLMLdRLSGKILHIDFGDCFEvaMTREKF---PEKIPFRLTR 877
Cdd:cd05175    226 NIMV-KDDGQLFHIDFGHFLD--HKKKKFgykRERVPFVLTQ 264
PI3Kc_C2_gamma cd05177
Catalytic domain of Class II Phosphoinositide 3-kinase gamma; PI3Ks catalyze the transfer of ...
642-919 1.76e-06

Catalytic domain of Class II Phosphoinositide 3-kinase gamma; PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. The class II gamma isoform, PI3K-C2gamma, is expressed in the liver, breast, and prostate. PI3Ks play an important role in a variety of fundamental cellular processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, immune cell activation and apoptosis. They can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class II PI3Ks preferentially use PtdIns as a substrate to produce PtdIns(3)P, but can also phosphorylate PtdIns(4)P. They function as monomers and do not associate with any regulatory subunits. Class II enzymes contain an N-terminal Ras binding domain, a lipid binding C2 domain, a PI3K homology domain of unknown function, an ATP-binding cataytic domain, a Phox homology (PX) domain, and a second C2 domain at the C-terminus. It's biological function remains unknown. The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270721 [Multi-domain]  Cd Length: 354  Bit Score: 52.20  E-value: 1.76e-06
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  642 PNQPIIRIQSI-APSLQVITSKQRPRKLTIMGSN--GHEFMFLLKGHEDLRQDERVMQLFGLVntllanDPASLRKNLSI 718
Cdd:cd05177     53 PLNPALRVKGIdADACSYFTSNAAPLKISFINANplAKNISIIFKTGDDLRQDMLVLQIVRVM------DNIWLQEGLDM 126
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  719 QRYAVIPLST--NSGLIGWVPHCDTLHALIRDYrekkKILLNIEHRIMLRMAPDYDHLTlmekvEVFEHAVNNtagddla 796
Cdd:cd05177    127 QMIIYRCLSTgkTQGLVQMVPDAVTLAKIHRES----GLIGPLKENTIEKWFHMHNKLK-----EDYDKAVRN------- 190
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  797 kllwlkspssevwfdrrtnYTRSLAVMSMVGYILGLGDRHPSNLMLDRlSGKILHIDFGDCFEVAMTREKFP-EKIPFrl 875
Cdd:cd05177    191 -------------------FFHSCAGWCVVTFILGVCDRHNDNIMLTH-SGHMFHIDFGKFLGHAQTFGSIKrDRAPF-- 248
                          250       260       270       280       290
                   ....*....|....*....|....*....|....*....|....*....|..
gi 1878422027  876 trMLTNAMEVTGLDG--------NYRITCHTVMEVLREHRDSVMAVLEAFVY 919
Cdd:cd05177    249 --IFTSEMEYFITEGgkkpqrfqRFVELCCRAYNIVRKHSQLLLNLLEMMLH 298
PI3Kc_C2_beta cd00895
Catalytic domain of Class II Phosphoinositide 3-kinase beta; PI3Ks catalyze the transfer of ...
642-855 2.71e-06

Catalytic domain of Class II Phosphoinositide 3-kinase beta; PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. The class II beta isoform, PI3K-C2beta, contributes to the migration and survival of cancer cells. It regulates Rac activity and impacts membrane ruffling, cell motility, and cadherin-mediated cell-cell adhesion. PI3Ks play an important role in a variety of fundamental cellular processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, immune cell activation and apoptosis. They can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class II PI3Ks preferentially use PtdIns as a substrate to produce PtdIns(3)P, but can also phosphorylate PtdIns(4)P. They function as monomers and do not associate with any regulatory subunits. Class II enzymes contain an N-terminal Ras binding domain, a lipid binding C2 domain, a PI3K homology domain of unknown function, an ATP-binding cataytic domain, a Phox homology (PX) domain, and a second C2 domain at the C-terminus. The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 119421 [Multi-domain]  Cd Length: 354  Bit Score: 51.54  E-value: 2.71e-06
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  642 PNQPIIRIQSIAP-SLQVITSKQRPRKLTIMGSN--GHEFMFLLKGHEDLRQDERVMQLFGLVNTLLANDPASLRknLSI 718
Cdd:cd00895     53 PLSPSLLVKGIVPrDCSYFNSNAVPLKLSFQNVDplGENIRVIFKCGDDLRQDMLTLQMIRIMNKIWVQEGLDMR--MVI 130
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  719 QRYavipLSTNSGligwvphcdtlhalirdyrekkkillniehRIMLRMAPDYDHLtlmEKVEVfEHAVNNTAGD-DLAK 797
Cdd:cd00895    131 FRC----FSTGRG------------------------------RGMVEMIPNAETL---RKIQV-EHGVTGSFKDrPLAD 172
                          170       180       190       200       210
                   ....*....|....*....|....*....|....*....|....*....|....*...
gi 1878422027  798 LLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLdRLSGKILHIDFG 855
Cdd:cd00895    173 WLQKHNPTEDEYEKAVENFIYSCAGCCVATYVLGICDRHNDNIML-KTTGHMFHIDFG 229
PI3Kc_IB_gamma cd00894
Catalytic domain of Class IB Phosphoinositide 3-kinase gamma; PI3Ks catalyze the transfer of ...
800-876 1.11e-03

Catalytic domain of Class IB Phosphoinositide 3-kinase gamma; PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Kgamma signaling controls diverse immune and vascular functions including cell recruitment, mast cell activation, platelet aggregation, and smooth muscle contractility. It associates with one of two regulatory subunits, p101 and p84, and is activated by G-protein-coupled receptors (GPCRs) by direct binding to their betagamma subunits. It contains an N-terminal Ras binding domain, a lipid binding C2 domain, a PI3K homology domain of unknown function, and a C-terminal ATP-binding cataytic domain. PI3Ks can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class I PI3Ks are the only enzymes capable of converting PtdIns(4,5)P2 to the critical second messenger PtdIns(3,4,5)P3. Class I enzymes are heterodimers and exist in multiple isoforms consisting of one catalytic subunit (out of four isoforms) and one of several regulatory subunits. They are further classified into class IA (alpha, beta and delta) and IB (gamma). The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases.


Pssm-ID: 270627 [Multi-domain]  Cd Length: 367  Bit Score: 43.31  E-value: 1.11e-03
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027  800 WLKS--PSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRlSGKILHIDFGdcfEVAMTREKF----PEKIPF 873
Cdd:cd00894    182 WLKEkcPIEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITE-TGNLFHIDFG---HILGNYKSFlginKERVPF 257

                   ...
gi 1878422027  874 RLT 876
Cdd:cd00894    258 VLT 260
PRK05755 PRK05755
DNA polymerase I; Provisional
1281-1471 4.99e-03

DNA polymerase I; Provisional


Pssm-ID: 235591 [Multi-domain]  Cd Length: 880  Bit Score: 42.00  E-value: 4.99e-03
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1281 SLMSKPEPQMYKVLAETNCQFISSLEDLAALNEKLNQTTEFAVDLEHHSYRSF----LGITclmqISTREED-FIIDTLE 1355
Cdd:PRK05755   278 SLLRRAAAAEAAPLDEEDYETILDEEELEAWLAKLKAAGLFAFDTETTSLDPMqaelVGLS----FAVEPGEaAYIPLDQ 353
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1878422027 1356 LRSEMY-VLNESFTNPSIVKVFHGADSDIEWLqKDFGLYVVNM-FDTHQASRSLNLGRN-SLDHLLKVFCNVDS------ 1426
Cdd:PRK05755   354 LDREVLaALKPLLEDPAIKKVGQNLKYDLHVL-ARYGIELRGIaFDTMLASYLLDPGRRhGLDSLAERYLGHKTisfeev 432
                          170       180       190       200
                   ....*....|....*....|....*....|....*....|....*.
gi 1878422027 1427 -NKRFQLADwrirPLPEEMIKYAQADTHYLLYVYDRLRADLFDAAN 1471
Cdd:PRK05755   433 aGKQLTFAQ----VDLEEAAEYAAEDADVTLRLHEVLKPKLLEEPG 474
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH